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ABSTRACT
MODULATION OF OXIDATIVE STRESS IN THE RETINAL PIGMENT
EPITHELIUM BY ENDOGENOUS PIGMENTATION
AND ACCESSIBLE THERAPEUTICS
Sally M. Yacout, PhD
Department of Chemistry and Biochemistry
Northern Illinois University, 2018
Elizabeth R. Gaillard, Director
Age-related changes to endogenous pigments in the retinal pigment epithelium (RPE) are
thought to significantly contribute to the etiology and progression of retinal diseases, such as
Age-related macular degeneration (AMD). The research in this dissertation studies the
modulation of oxidative stress by melanin and the efficacy of accessible therapeutics in
attenuating damage to the RPE.
Structural and functional characteristics of RPE melanin were studied, including agerelated changes in donor melanin. Young melanin provides significant protection to photostressed RPE cells, while aged human donor melanin is capable of pro-oxidant behavior in cells.
Structural characterization of aged human donor melanin suggests oxidative degradation of the
pigment over time, which may contribute to decreased antioxidant capacity. Immunomodulation
by RPE melanin was also studied in conjunction with the effects of glycated extracellular matrix
proteins. Results show that melanin pigmentation modulates expression of the cytokine

interleukin-6 (IL-6) and suggest a novel role for melanin in regulating immune and inflammatory
mechanisms in the RPE.
With increasing age, the antioxidant infrastructure of the RPE declines, resulting in
unregulated oxidative stress and development of diseases such as AMD. The efficacy of plantderived antioxidants in attenuating blue-light-mediated oxidative stress in RPE cells was studied.
Low doses of these dietary antioxidants significantly attenuate oxidative damage to RPE cells
and are an accessible supplement. Liposomal delivery of L-DOPA supplements was also studied
as a treatment option for AMD. This delivery system for L-DOPA stabilizes the supplement,
preventing the formation of cytotoxic oxidation products. The supplements studied can serve as
low-cost, accessible therapeutics for treatment and prevention of retinal damage and disease
progression.
The molecular mechanisms of aging are complex and multifaceted. In the retina, changes
to endogenous pigmentation over time promote cell damage and disease progression. The
functional role of melanin in the RPE is not fully understood; however, the pigment appears to
play a significant role in modulating oxidative stress and inflammation. A better understanding
of how biochemical changes to the RPE contribute to the onset and progression of age-related
disease can better the development of therapeutics and target specific treatments.
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CHAPTER 1

INTRODUCTION

Vision is a fundamental sense that has advanced human evolution. With increasing age,
vision loss is experienced due to retinal degeneration. While a number of biochemical
mechanisms may be responsible for the onset and progress of vision loss, observations regarding
pigment change in the retina prompt questions about the role of melanin in the aging eye.
Age-related macular degeneration (AMD) is the leading cause of blindness in developed
countries (World Health Organization, 2017). Symptoms of this disease include blurred vision,
blank spots, and loss of high-resolution central vision. In 2010, the National Eye Institute
reported that 89% of AMD patients in the United States were Caucasian, with the remaining
portion of AMD cases being African American or Hispanic (National Eye Institute, 2010). This
overwhelming racial disparity in AMD cases suggests that pigmentation may play a role in the
pathogenesis of the disease. Age-related changes to melanin in the retina may alter essential
functions of the pigment, which normally protect the eye from internal and external stressors.
Previous studies have observed significant loss of retinal melanin with age (Rozanowski et al,
2008b; Sarna et al, 2003; Zadlo et al, 2009; Zareba et al, 2006). This loss of pigment can have
adverse effects on ocular health. Retinal abnormalities seen in conditions of absent
pigmentation, such as albinism, suggest a critical role for melanin in retinal health.
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This work aims to expand the understanding of the role of melanin in the retina by
investigating biochemical mechanisms of protection and damage facilitated by the pigment. This
work also investigates accessible therapeutics in attenuating and preventing retinal tissue
damage. By understanding the function of melanin in the retina, risk factors for retinal
degeneration and disease can be more accurately assessed and incorporated into preventative
treatments to preserve vision.

Overview of the Visual System

The rudimentary anatomy of the eye is depicted in Figure 1.1. As light enters the eye it is
projected through the cornea and further focused toward the posterior segment of the eye through
the pupil and the lens. Photons focused on the retina can then initiate visual transduction. In this
process, photons are absorbed by opsin-retinal protein complexes in photoreceptors, yielding
downstream electrical signaling. This signal is discharged by ganglion cells in the retina through
axons in the optic nerve, lastly reaching the brain where the signal is interpreted as a visual
image.
The convex surfaces of the cornea and lens allow for the refraction and focusing of light
onto the retina. The cornea is composed of an epithelial cell layer along the anterior surface
followed by a thick stromal layer and elastic layer, and lastly a monolayer of endothelial cells
covering the posterior surface of the elastic lamina. A key optic function of the cornea is the

3

Figure 1.1 Horizontal cross-section of the human eye (webvision.med.utah.edu; Kolb, 2005).
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absorption of light below 295 nm (Dillon et al, 1999). The iris is a body of circular tissue
suspended in the aqueous humor between the cornea and the lens. Muscular fibers in the iris
surround the pupil and work to regulate the amount of incoming light. The lens rests directly
behind the pupil and is surrounded by ciliary processes, which change the convexity of the lens
through forced contraction and expansion. This change in shape alters the refractivity of the
lens. Similar to the cornea, the lens not only focuses light but also behaves as a filter, absorbing
light between 295 and 400 nm (Dillon et al, 1999; Gaillard et al, 2000). Given these filtering
effects, only light greater than 400 nm in wavelength can reach the retina.
The retina is a multilayered system of tissue oriented between the choroid and vitreous.
Figure 1.2 shows a vertical section of the retina and the respective layers. Facing the anterior,
the retina contains a layer of nerve fibers that permeate the tissue moving toward the back of the
retina. Moving toward the posterior from this layer, the ganglion cell layer contains processes
that extend into the inner nuclear layer. The outer nuclear layer houses nuclear bodies of
photoreceptors. The photoreceptor layer contains rods and cones, which extend into the
processes of the pigmented epithelial layer. The photoreceptor outer segments contain opsinretinal complexes that function as visual pigment. 11-cis retinal serves as the prosthetic group
and chromophore for these protein complexes and undergoes photo-induced isomerization to alltrans retinal (Wald, 1968).
Rod photoreceptors use rhodopsin as a visual transduction protein and are primarily
responsible for visual sensation in dim light. Cone photoreceptors are responsible for color
vision, and in the human retina they contain respective pigments sensitive to blue, green, and red
wavelengths of light (Brown & Wald, 1964; Wald, 1961). The geography of the human retina
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Figure 1.2 Vertical cross-section of retina tissue layers (webvision.med.utah.edu; Kolb, 2005).
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varies in terms of rod and cone photoreceptor distribution. While the periphery of the retina is
dense in rods, the center region of the retina, known as the fovea, is exclusively cones (Curico et
al, 1990). The fovea is responsible for sharp high-resolution vision. At the center of the fovea is
the macula. Deterioration of the macula is most detrimental to vision, as this region is at the core
of the fovea.
The retina is supported by Bruch’s membrane. This membrane is a multilayered complex
of structural support proteins such as fibronectin and collagen. Bruch’s membrane rests against
the choroid from a posterior orientation. The choroid is a vascular membrane composed of a
dense capillary bed, circulating blood through the outermost layer of the retina, the retinal
pigment epithelium.

The Retinal Pigment Epithelium

The retinal pigment epithelium (RPE) is a monolayer of tightly packed, postmitotic cells
that form the blood-retina barrier. The health of the RPE is critical for maintaining the structure
and function of the retina and the visual system as a whole. The RPE participates in a number of
functions such as phagocytosis of spent photoreceptor outer segments, recycling of visual
pigment, nutrient transport and waste disposal for the retina, and secretion of regulatory
components such as cytokines.
RPE cells form tight hexagonal junctions as a result of cell-to-cell contact. Figure 1.3
shows a monolayer of human RPE cells forming these junctions. The basal border of the RPE is
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Figure 1.3 Human retinal pigment epithelial cell layer with hexagonal junctions. Stained for
ZO-1 and occludin junction proteins (Sonoda et al, 2010).
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Bruch’s membrane, where hemidesmosome-type adhesions have been observed between RPE
cells and Bruch’s membrane (Miki et al, 1975). These connections between the RPE basement
membrane and inner Bruch’s membrane are characteristic of cell-extracellular matrix
attachment. Apical processes connect RPE cells to photoreceptor outer segments. Microvilli at
the apical surface of the RPE surround the outer segments and participate in phagocytosis of rod
and cone outer segment discs (Hogan et al, 1974). Figure 1.4 shows the orientation of the RPE
with Bruch’s membrane and photoreceptors.
Phagocytizing photoreceptor outer segments is a critical function of the RPE. It has been
estimated that each RPE cell is responsible for the phagocytosis and turnover of 30 – 45 outer
segments (Young, 1971). These outer segments are composed of flattened membrane discs, with
each photoreceptor synthesizing approximately 10% of outer segment daily. As new discs are
added to the base of the outer segment, terminal discs are shed and phagocytized by the RPE.
The degraded disc packets are then moved through the choroid for disposal. Photoreceptors exist
in an oxidative environment where there is constant exposure to radiation from incoming
sunlight, as well as a high oxygen partial pressure from blood in the choroid (Winkler et al,
1999). The high concentrations of polyunsaturated fatty acids in photoreceptor outer segment
discs, in combination with an oxidative environment, make these membranes highly susceptible
to oxidative damage via overproduction of reactive oxygen species. Thus, outer segment
turnover is vital to the health of photoreceptors, and any lapse in RPE phagocytosis of outer
segments could yield substantial tissue damage.
The RPE plays a key role in the cycling of visual pigment, which is a necessary process
in visual transduction. In the disc membrane protein, rhodopsin, 11-cis retinal absorbs a photon
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Figure 1.4 Vertical cross-section showing photoreceptor, RPE, and Bruch’s membrane layers
(webvision.med.utah.edu; Strauss, 2005).
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Figure 1.5 The classic visual cycle diagram (photobiology.info/Crouch.html; Crouch, 2009).
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of light and is isomerized to the all-trans retinal species. This photoconversion deprotonates the
11-cis retinal-opsin Schiff base, resulting in the release of all-trans retinal from rhodopsin. Alltrans retinal is subsequently reduced to all-trans retinol. The conversion of all-trans retinol back
to 11-cis retinal is carried out in RPE cells. Figure 1.5 illustrates the classic visual cycle.
The RPE participates in a number of other critical functions in the retina, including
transport of nutrients and waste and providing a physical barrier to protect the neurosensory
retina. This physical barrier also makes the eye an immune-privileged site, sequestering the eye
from systemic immune factors. It has been generally accepted that this tight regulation protects
the eye from daily inflammatory events that may deteriorate ocular tissue and compromise
vision. Consequently, RPE cells can regulate local immune and inflammatory response in the
retina by expressing and secreting a variety of cytokines, complement factors, and antigens
(Benson et al, 1992; Elner et al, 1992).
RPE cells are postmitotic and are subject to a number of changes with age. RPE cells and
photoreceptors have been shown to decrease in number with increasing age. Further stress is put
on RPE cells, as there is a greater ratio of photoreceptors to RPE cells with age (Dorey & Wu,
1989). Additionally, there is an observable loss of RPE melanin with age (Sarna et al, 2003). It
is generally accepted that melanogenesis stops or slows in RPE cells after the first two years of
life in humans (Boulton, 1998; Schraermeyer & Heimann, 1999). With age, vitamin E and
antioxidant enzyme levels decrease in the RPE (Hayes, 1974; Katz et al, 1982; Liles et al, 1991).
Deficiencies in endogenous antioxidants and antioxidant enzymes in RPE cells increase the
susceptibility of these cells to severe oxidative stress and irreparable tissue damage.
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Melanin in the Retinal Pigment Epithelium

The RPE is pigmented by the heterogeneous polymer melanin. Melanin is derived from
the enzymatic oxidation of tyrosine into dihydroxyindolic species that are polymerized inside
melanosome organelles. This pigment exhibits protective qualities in the RPE; however, the loss
of melanin and structural modifications to melanin with age can promote oxidative stress by
inducing the generation of reactive oxygen species (Korytowski et al, 1987; Sarna et al, 1985).
Melanogenesis in the RPE begins early in fetal development and is a multistage process.
Functional tyrosinase is necessary in the early stages of this process (Giebel & Spritz, 1992).
Tyrosinase activity ceases in the final stage of melanogenesis in human RPE cells and
polymerization of melanin stops after 2 years of age (Boulton, 1998; Schraermeyer & Heimann,
1999). Figure 1.6 shows the biosynthetic pathways for the two types of melanin, eumelanin and
pheomelanin. The oxidation and polymerization of dihydroxyindole (DHI) and 5,6dihydroxyindole-2-carboxylic acid (DHICA) yield eumelanin, while cysteinyldopas react with
dopaquinone to form cysteinyldopaquinones in the production of pheomelanin. RPE melanin is
predominantly eumelanin. Melanin density in the RPE increases 2-fold in the macula compared
to the paramacular regions, and melanin density is at a maximum where the RPE ends and
transitions into the ciliary body. The distribution of melanin in RPE cells is extremely polarized,
with most melanin located in the apical section of the cell in young human donors (Weiter et al,
1986). Morphologically, melanosomes in the human RPE are elliptical and the melanin itself is
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Figure 1.6 Biosynthetic pathway for eumelanin and pheomelanin (ommbid.mhmedical.com; doi:
10.1036/ommbid.256).
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surrounded by a lipid bilayer. Melanosomal phospholipids in the RPE contain more
polyunsaturated fatty acyl chains compared to uveal melanosomes in the human eye (Ward &
Simon, 2007). With age, the morphology of the melanosome becomes more spherical as
melanin-lysosome granules, known as melanolipofuscin, increase.
The functions of melanin in the RPE have not been fully elucidated. As a material,
melanin is difficult to study, as it is generally insoluble and heterogeneous in structure. RPE
melanin is typically dark brown or black in coloration and absorbs broadly across the UV
spectrum. In addition to behaving as an optical filter, RPE melanin also behaves as an
antioxidant (Z. Wang et al, 2006a). The redox properties of melanin make it an effective
material for scavenging free radicals and reducing reactive species in the cellular environment.
In eumelanin, electron transfer is facilitated by DHI and DHICA subunits via the redox triad
between quinone, semiquinone, and hydroquinone species. In this respect, melanin is able to
reduce superoxide radicals formed during the phagocytosis of photoreceptor outer segments in
RPE cells. Melanin can also scavenge semioxidized carotenoids in the RPE, regenerating the
protective parent compound (Edge et al, 2000). The chemical structure of melanin also
facilitates quenching of singlet oxygen and electronically excited photosensitizers (Sarna, 1992).
In the RPE, melanin can bind cationic photosensitizers such as the bisretinoid pyridinium
compound, A2E, returning the excited molecule to the ground state and preventing
photodegradation of A2E into reactive aldehydes (Z. Wang et al, 2006b). Additionally, melanin
can sequester redox active metal ions that can catalyze the formation of reactive oxygen species
in the cell (Hong & Simon, 2007). It is also possible that melanin can mediate cell-signaling
events in the RPE as downstream or direct effects of the aforementioned qualities.
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AMD is prevalent among Caucasians, with low incidence in African American and
Hispanic populations (National Eye Institute, 2010). This trend suggests a role for pigmentation
in AMD pathogenesis. It has been established that melanin protects the RPE and is necessary in
the retina. Albinism, a condition where melanin pigment is absent, highlights the necessity of
melanin in the retina. Those affected by the condition experience a number of retinal
abnormalities in their lifetime due to irregular development of the neurosensory retina
(Summers, 2009). X-linked ocular albinism is caused by mutations to GPR143, a G-protein
coupled receptor. This protein is also identified at OA1. The gene for GPR143 is expressed
only in pigmented cells, such as RPE cells. The ligand for this protein is L-DOPA, an
intermediate of melanin synthesis (Lopez et al, 2008). GPR143 also controls secretion of
pigment epithelium-derived growth factor (PEDF) in the RPE. PEDF is a neurotrophic and
antiangiogenic factor supporting neurosensory development and preventing neovascularization.
A lack of PEDF secretion by RPE cells may explain retinal abnormalities and deficiencies
observed with albinism, as pigmented-dependent signaling would be absent. Reduction of PEDF
secretion may also explain the racial discrepancy observed in the AMD demographic. This
theory is supported by a meta-analysis study of AMD patients taking L-DOPA for movement
disorders such as Parkinson’s disease. The study found that L-DOPA use was associated with an
eight-year delay in the onset of AMD and significantly reduced incidence of AMD (Brilliant et
al, 2016). While this study can only establish a strong relationship between L-DOPA use and
attenuating AMD, it does support the idea that pigmentation in the RPE is participating in cell
signaling events.
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Figure 1.7 Age-related changes to human RPE melanin granules.
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With increasing age, melanin concentration significantly decreases in the human RPE (FeeneyBurns et al, 1984; Sarna et al, 2003; Weiter et al, 1986). Figure 1.7 shows the age-related
changes to RPE pigment granule content. As melanin concentrations decline and
melanolipofuscin granules increase, the properties of melanin change, favoring pro-oxidant over
antioxidant behavior. Aged melanosomes in the human RPE exhibit a number of cytotoxic
properties, which are exacerbated by exposure to green and blue light. Aged human RPE
melanosomes can induce RPE cell death upon light exposure, suggesting phototoxicity of aged
melanin (Rozanowski et al, 2008a). The loss of melanin and changes in RPE melanin with age
may contribute to the etiology of retinal diseases such as age-related macular degeneration
(AMD). It is also possible that degraded melanin in the RPE contributes to a proinflammatory
cellular environment.

Bruch’s Membrane

Bruch’s membrane (BM) is located between the choroid and the retina, separating the
basal surface of the RPE from blood in the choroid. This membrane is relatively thin, ranging
from 2 – 4 µm in thickness and is an acellular construct (Rizzolo et al, 2007). The extracellular
matrix composition of BM consists of five layers: the RPE basal lamina, the inner collagenous
layer, the elastic layer, the outer collagenous layer, and the choriocapillaris basal lamina. The
location and structure of BM functionalizes the membrane as a substrate for the RPE and a vessel
wall for the posterior of the eye.
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BM is predominately composed of collagen, fibronectin, laminin, heparin sulfate, and
chondroitin sulfate (Das et al, 1990; Huang et al, 2007; Loffler & Lee, 1986). BM provides vital
structural support and anchorage to RPE cells, without which RPE cells will die. In addition to
providing structural support, integrins present on BM facilitate cell signaling. RPE cells
synthesize laminins that specifically interact with these integrins and also synthesize
extracellular matrix (ECM) components such as collagen IV and fibronectin (Aisenbrey et al,
2006; Campochiaro et al, 1986). BM provides a physical barrier between the RPE and the
choroidcapillaris, ideally preventing the passage of blood vessels to the RPE. BM also
selectively regulates the passage of molecules, such as nutrients and waste, from either the
choroid or RPE (Sellner, 1986). In this respect, BM is necessary in maintaining the blood-retina
barrier and in preventing damage to photoreceptors via fluid leakage into the retina.
BM is subject to significant changes with age and is believed to age in parallel with the
RPE. With increasing age, BM shows significant modifications to collagen and elastic layers
and increases in thickness due to accumulation of RPE phagocytosis and waste products (Hogan
et al, 1971). Under the macula, there is a 2 – 3-fold thickening of BM through adulthood,
noticeably in the outer collagenous layer (Killingsworth, 1987; Ramrattan et al, 1994). There is
also an increase in glycoconjugates and collagen cross-linking (Karwatowski et al, 1994;
Newsome et al, 1987). Long-lived ECM proteins in BM are subject to nonenzymatic
modifications via Maillard reactions, yielding advanced glycation end products, which have been
found to accumulate in BM with age (Handa et al, 1999).
The formation of drusen deposits in BM is among the most significant indicators of
aging. These extracellular deposits are found between the RPE basal lamina and the inner
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collagenous layer. Drusen are commonly found in older adults and are classified as hard or soft
granules (Klein et al, 1992; Van der Schaft et al, 1992). Soft drusen have been associated with a
higher risk of disease (Davis et al, 2005; Klein et al, 1991; Klein et al, 2007; Sarks, 1980).
Notably, while drusen accumulate less in the macula than the periphery of the retina, soft drusen
are only found in the macula (Rudolf et al, 2008). It is generally accepted that drusen form via
the deposition of RPE waste products into BM. Drusen are predominantly lipids but also contain
RPE cellular components (Hageman et al, 2001). Interestingly, about 6% of drusen composition
is melanin, suggesting the RPE pigment may play a role in drusen formation (Rudolf et al,
2008). Arrow 15 in Figure 1.8 highlights melanin granule deposits in macular drusen from
human donor tissue. The composition of drusen deposits in the subretinal space mirrors
extracellular deposits in age-related diseases such as atherosclerosis and amyloidosis, suggesting
underlying similarities in the pathogenesis of retinal diseases, such as AMD, to other age-related
diseases (Mullins et al, 2000). Complement proteins involved in inflammatory processes have
been found in drusen deposits, further supporting the relation of these deposits to disease
progression (Anderson et al, 2002; Hageman et al, 2005).
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Figure 1.8 Melanin pigment granules in macular hard drusen (Rudolf et al, 2008).

The formation of advanced glycation end products (AGEs) is a well-established
occurrence during aging. These adducts form via Maillard reactions between amine-containing
protein residues and reducing sugars and α-oxaloaldehydes (Monnier et al, 1992). Structural
proteins such as collagens are highly susceptible to these modifications, as there is little to no
protein turnover in collagen-containing bodies. AGEs contribute not only to structural
modifications that promote disease but also to functional disruptions. AGEs can induce
transcriptional changes in the subretinal space, and binding of AGEs to cellular receptors can
initiate oxidative stress by activating proinflammatory signaling factors such as NF-κB (Tian et
al, 2005; S.D. Yan et al, 1994). The accumulation of AGEs increases in the RPE-BM space with
age (Glenn et al, 2009; Handa et al, 1999). In addition to the accumulation of drusen deposits
with advancing age, the downstream effects of structural modifications to BM gives evidence for
the role of oxidative stress and inflammation in diseases of the retina, such as AMD.
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Oxidative Stress and Inflammation in the Retina

Oxidative stress is a mechanism of cellular damage that has been proposed in the
pathogenesis of a number of diseases and disorders that progress with age. In the retina,
oxidative stress has been implicated in the pathogenesis of diseases such as AMD. Oxidative
stress can be induced by a number of cellular events that yield free radicals such as super oxide
anion, hydroxyl radicals, singlet oxygen, and nitric oxide. The environment of the retina makes
the tissue extremely susceptible to production of reactive oxygen species (ROS) due to constant
light exposure, high concentrations of polyunsaturated fatty acids, presence of endogenous
photosensitizers, and the oxidative metabolism of photoreceptor outer segments (Winkler et al,
1999).
ROS have detrimental effects on the cellular environment, causing DNA damage and
irreversible modifications to lipids and proteins. These alterations to the cellular environment
can ultimately inhibit RPE cell function, resulting in RPE cell death and photoreceptor
detachment. Light exposure to the retina produces ROS and supports the relation of photic stress
to retinal damage (Dayhaw-Barker, 1987; Marshall, 1985). Intense light exposure can induce
lipid peroxidation in the retina and has also been shown to induce photoreceptor atrophy (Borges
et al, 1990; Tso, 1985; Wiegand et al, 1983). There is also wavelength dependence on ROS
generation in the retina due to the presence of endogenous photosensitizers, such as lipofuscin.
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Lipofuscin is present in high concentrations in AMD eyes and has been shown to increase
oxygen uptake in blue-light-exposed human RPE cells (Winkler et al, 1999).
The causative connection between oxidative stress and AMD is further supported by
studies that have observed retinal damage in animals with nutrient and antioxidant deficiencies.
Vitamin E deficiencies in conjunction with photic stress have been shown to increase retinal
damage, while supplements of vitamin C or synthetic antioxidants have been shown to lessen
damage to the retina (Hayes, 1974; Katz et al, 1982; Organisciak et al, 1992; Organisciak et al,
1990). With age, lower levels of antioxidant enzymes, such as catalase, have been observed in
the human RPE (Liles et al, 1991). The RPE does contain endogenous pigments, such as
carotenoids and melanin, that can provide further protection to the retina by reducing ROS
generation. In addition to an oxidative environment, the retina experiences a decline in
antioxidant defenses with increasing age. The oxidation of lipids and proteins in the retina can
induce a number of functional changes that yield deleterious effects, such as increased drusen
formation (Crabb et al, 2002; Gu et al, 2003; Handa et al, 1999).
Oxidative stress can also instigate inflammation in the retina. Photo-oxidation of
lipofuscin has been shown to stimulate inflammasome activation in RPE cells (Brandstetter et al,
2015). Filtering of blue light has been shown to decrease RPE-choroid ROS levels and suppress
proinflammatory cytokine expression in vivo (Narimatsu et al, 2015). Additionally, oxidized
lipids and proteins can directly stimulate inflammation. AGEs in Bruch’s membrane can interact
with receptors in the RPE to activate transcriptional factors that upregulate inflammatory
response, such as cytokines and angiogenic factors (Higgins et al, 2003). It is also possible to
stimulate production of reactive species in the RPE via chronic inflammation. Studies have
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shown that nitric oxide production can be induced in RPE cells by cytokine and endotoxin
stimulation, an example being immunostimulation of nitric oxide production in bovine RPE cells
by IFN-γ, TNF-α, and LPS (Goureau et al, 1994; Goureau et al, 1992). Subsequent studies have
used these immunostimulants to investigate cellular regulation of iNOS in the bovine and murine
RPE cells (Faure et al, 1997; Goureau et al, 1993; Koga et al, 2003; Liversidge et al, 1994;
Vodovotz et al, 1996). Immunostimulation of iNOS in RPE cells has been clearly established by
past studies, however, information examining the effects of photic stress in inducing iNOS and


NO production in RPE cells in vitro and in vivo is lacking. It is possible that photic stress could

mediate an inflammatory response upregulating cytokines that induce iNOS in these cells.
Additionally, endogenous components such as melanin may contribute to NO production in the
RPE through post translational mechanisms. It is possible that melanin in the RPE regulates
immune response and inflammation, either by attenuating oxidative stress or by direct regulation
of inflammatory components. The role of melanin in immune response is largely unexplored,
but studies have shown that melanocytes in the epidermis are capable of producing cytokines and
facilitate cross-talk mechanisms with neighboring cells (Gasque & Jaffar-Bandjee, 2015). The
administration of fungal melanin to mice with alcohol induced liver injuries has been shown to
down-regulate iNOS activity, and proinflammatory cytokine levels were normazlied with
melanin treatments in autoimmune compromised rats (Avramidis et al, 1998; Song et al, 2016).
With degradation, it is possible that melanin fragments may behave as damage-associated
molecular patterns that activate inflammatory response in the RPE.
In addition to direct measurements of inflammatory activity in the retina, the analysis of
drusen deposit composition provides evidence for the role of inflammation in retinal damage
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with advancing age. Previous studies have found complement pathway proteins,
immunoglobulin, and immune response regulation proteins, such as apolipoprotein E, in drusen
samples (Hageman & Mullins, 1999; Hageman et al, 1999; Mullins et al, 2000). A genetic
variant of complement factor H (Cfh) has been identified in AMD patients and confers increased
risk for developing the disease (Edwards et al, 2005; Haines et al, 2005; Klein et al, 2005). The
Cfh gene expresses a complement factor protein responsible for inflammatory regulation in RPE
cells. The observed Y402H mutation to CFH protein may cause dysfunction resulting in
unregulated inflammation. It has been observed that AMD patients homozygous for the CFH
variant have higher levels of systemic IL-6 and TNF-α compared to heterozygous and non-risk
variants (S. Cao et al, 2013). The activation of proinflammatory cytokines by ROS and reactive
nitrogen species (RNS) can propagate cellular damage and contribute to the pathological
phenotype of the degenerating retina.

Dissertation Research

In the retina, the molecular mechanisms of aging and age-related diseases can be
influenced by a number of intracellular biochemical changes in the RPE and the extracellular
environment. A substantial component of these mechanistic changes may be attributed to
depletion of cellular antioxidants from the RPE, increasing susceptibility to tissue damage via
oxidative stress (Liles et al, 1990).
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RPE cells anchor photoreceptors and provide adherence of the retina by attachment to
Bruch’s membrane. Compromise to RPE cell function can result in detachment of retinal layers
and vision loss. Due to the oxidative environment surrounding these cells, they are a primary
site for retinal damage. RPE cells contain a number of antioxidants, such as melanin, to protect
the cells against these environmental factors. This dissertation studies age-related changes to
melanin and investigates accessible supplements for attenuating and preventing RPE cell
damage.
With increasing age, RPE melanin decreases and the accumulation of photosensitizers
such as lipofuscin and melanolipofuscin increases (Feeney-Burns et al, 1984; Sarna et al, 2003;
Weiter et al, 1986). Evidence has shown that melanin behaves as a photoprotectant and
antioxidant in the RPE; however, the mechanistic role of RPE melanin in modulating cellular
events has been largely, if not entirely, unexplored (Edge et al, 2000; Hong & Simon, 2007;
Sarna, 1992; Z. Wang et al 2006a). This dissertation probes the role of RPE melanin in
regulating immune response and oxidative stress in the RPE. These events are monitored under
photic stress, with modifications to RPE cell protein substrates. Additionally, age-related
changes to RPE melanin are characterized. This work also studies accessible treatments using
antioxidant and therapeutic compounds for attenuating and preventing oxidative stress in RPE
cells.
This dissertation research addresses the connection between age-related changes to RPE
melanin and the modulation of oxidative stress by the pigment. The benefits of antioxidant and
therapeutic compounds are also studied, which may provide accessible treatments to supplement
protective factors in the RPE.

CHAPTER 2
MATERIALS AND METHODS

Materials

Callistephin chloride (≥ 90% purity), oenin chloride (≥ 90% purity), 3-(3,4Dihydroxyphenyl)-L-alanine (L-DOPA; ≥ 98% purity), 2’-7’-dichlorodihydrofluorescin
diacetate (H2DCFDA), 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide (MTT), 3Amino-7-dimethylamino-2-methylphenazine hydrochloride (Neutral red), 3,6Bis(dimethylamino)acridine hydrochloride zine chloride double salt (acridine orange), L-αphosphatidylcholine (egg yolk; ≥ 40%), cholesterol (≥ 99 %), methylglyoxal, glycolaldehyde,
synthetic melanin, and sinapinic acid were purchased from Sigma-Aldrich Chemical Company
(St. Louis, MO). Black latex beads, 1.00 µm in diameter and nonfunctionalized, were purchased
from Polysciences, Inc. (Warrington, PA).
Dulbecco’s Modified Eagle’s Medium (DMEM), fetal bovine serum, L-glutamine, and
penicillin-streptomycin solution were also purchased from Sigma-Aldrich. TrypLE and 4amino-5-methylamino-2’,7’-difluorofluorescein diacetate (DAF-FM) were purchased from
Thermo Fisher Scientific (Waltham, MA). TRIsure reagent was purchased from Bioline (New
South Wales, Australia). Moloney murine leukemia virus reverse transcriptase was purchased
from Promega (Madison, WI). Bullseye EvaGreen qPCR Master Mix was purchased from
MidSci (St. Louis, MO). Direct-zol RNA Miniprep Plus columns were purchased from Zymo
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Research (Irvine, CA). Human IL-6 ELISA kit was purchased from PeproTech (Rocky Hill,
NJ). Ethanol (100%) was purchased from Ultrapure (Darien, CT). All other organic solvents
used were HPLC grade and purchased from Sigma-Aldrich. Water was purified through a
Millipore Milli-Q Plus PUREpak 2 system.

Instrumentation

UV-Vis data was collected using an Ocean Optics spectrophotometer (Dunedin, FL).
Steady-state fluorescence was measured using a Hitachi F-2500 fluorescence spectrophotometer
(Hitachi Ltd., Tokyo, Japan). LC/MS analysis was performed using an LCQ Advantage mass
spectrometer system with a Surveyor LC pump and PDA detector (Thermo Finnigan, Waltham,
MA). LC/MS with structure prediction was done using a Shimadzu LCMS-IT-TOF and
MALDI-TOF analysis was done using a Shimadzu MALDI-7090 (Kyoto, Japan). Absorbance
of plated ARPE-19 cells was done using an Epoch plate reader (BioTek, Winooski, VT).
Quantitative real-time PCR (qPCR) was performed using a ViiA 7 real-time PCR system (Life
Technologies, Carlsbad, CA). Cells were sorted using a Becton Dickinsin FACSCalibur flow
cytometer (Franklin Lakes, NJ). Cell morphology was monitored using a Nikon inverted
microscope ECLIPSE TS100 (Nikon Instruments Inc., Melville, NY). Dynamic light scattering
(DLS) was done using a Brookhaven BI-200SM research goniometer and laser light scattering
system (Holtsville, NY).
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Methods

Cell Culture

ARPE-19 cells purchased from American Type Culture Collection were used. Cells were
authenticated by short tandem repeat (STR) analysis as shown in the Appendix. STR analysis
was performed at the Genetic Resources Core Facility at Johns Hopkins University (Baltimore,
MD) using the GenePrint 10 System (Promega, Madison, WI). Cells were maintained in
Dulbecco’s Modified Eagle Medium supplemented with 10% fetal bovine serum, 1.1% Lglutamine, and 1.1% antibiotic/antimycotic at 37°C in a 5% CO2 humidified incubator. Cells
were plated on 24-well or 12-well plates with an initial seeding density of 5 x 104 cells/mL; 24well plates were used for MTT and Neutral Red assays and 12-well plates were used for
H2DCFDA, DAF-FM, and IL-6 expression and secretion experiments and for rate of cell
attachment assays. Cells were seeded onto ECMs or tissue-culture-treated plates (no ECM) at a
density of 250,000 cells/mL for 24-hour attachment experiments and 500,000 cells/mL for 30minute attachment experiments. Cells from passages 7 – 30 were used.

Melanin Extraction and Purification

Eyes were dissected as follows: excess fat was removed and an incision was made in the
sclera approximately 1 cm from the outer cornea. The anterior and posterior segments were
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separated, the vitreous was removed and the eyecup was filled with 0.32 M phosphate-buffered
sucrose. The RPE cells were then gently brushed away from the isolated posterior segment.
Isolated RPE cells were then homogenized and centrifuged at 100 x g for 8 min at 4°C.
Supernatant was collected and centrifuged at 3,200 x g for 10 min at 4°C. Calf melanosomes
were resuspended in PBS and layered on a 2.25 M sucrose solution and centrifuged at 8,200 x g
for 50 min at 4°C. Human melanosomes were layered onto a three-step gradient of 0.63 M, 1.37
M, and 2.25 M sucrose solutions and centrifuged at 8,200 x g for 50 min at 4°C to separate
lipofuscin and melanolipofuscin from the melanin granules. Melanosomes were then washed
three times with Milli-Q water and lyophilized. Lyophilized melanin was stored at -70°C. For
experimental use, melanin was suspended in a 50:50 ethanol/sterile water solution and
homogenized to break up aggregates prior to ARPE-19 cell uptake. Calf eyes were provided by
Brown Packing Company (New Holland, IL). Human donor eyes were provided by Eversight
Eye Bank (Chicago, IL).

Granule Phagocytosis and Supplement Uptake by RPE Cells

Calf melanin, human melanin, and black latex bead granules in media were counted using
a hemacytometer and fed to cells at a density of 5 - 6 x 106 granules/mL. Cells were fed granule
suspensions in complete media for four days, not exceeding 5 µL of EtOH per 1 mL of media.
Cells were washed with PBS prior to melanin feeding each day. Unpigmented cells were
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Figure 2.1 ARPE-19 cells pigmented with A) black latex beads B) human donor melanin, or C)
calf melanin.
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supplemented with vehicle containing no granules. Figure 2.1 shows ARPE-19 cells pigmented
with calf melanin, black latex beads, or human donor melanin.
Anthocyanins were fed to confluent cells at concentrations of 0, 0.1, or 1 µg/mL in
serum-free media. Cells were incubated for 30 min with anthocyanin-containing media prior to
irradiation or dark treatment. Media was removed and cells were washed with PBS prior to
irradiation.
For L-DOPA experiments, cells were supplemented with 10 µM L-DOPA or matched
starting material concentration of oxidation products in media. For liposome experiments,
encapsulated L-DOPA concentration was matched to L-DOPA supplement given directly in cell
media. Control cells were supplemented with vehicle or buffer-encapsulated liposomes. Cells
were incubated for either one day, three days, or five days with supplement post irradiation.

Irradiation of RPE Cells

For blue light irradiation experiments, cells were layered with PBS and subjected to
irradiation with a Philips “special blue” Bilirubin bulb through a 1/4 inch thick sheet of Plexiglas
for 30 min. Control cells were covered and subjected to dark treatment for 30 min. Plates were
positioned 4 inches under two 24-inch bulbs.
For UV-B irradiation experiments, Philips TL/01 Phototherapy bulbs were used, with
narrowband emission at 311 nm. Cells were washed and layered with PBS and irradiated for 10
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min on ice. Dark-treated cells were covered with foil and subjected to the same conditions.
Plates were positioned 8 inches under two 24-inch bulbs.
For UV-C experiments, cells were washed and layered with PBS and irradiated for 15
secs or subjected to dark treatment under the same conditions. Plates were positioned 6 inches
under an 11-inch Ushio G8T5 germicidal UV-C bulb with a 254 nm output.

Detection of Intracellular Reactive Oxygen Species and Nitric Oxide in RPE Cells

Intracellular reactive oxygen species (ROS) were detected using H2DCFDA and
intracellular nitric oxide was detected using DAF-FM. When reacted with their respective
substrates, these probes will fluoresce. For ROS detection experiments, cells were incubated
with 1 µM H2DCFDA in PBS for 20 min immediately following irradiation. For anthocyanin
studies, cells were incubated with H2DCFDA prior to blue light exposure. Solutions containing
H2DCFDA were subjected to 30 min of blue light irradiation to ensure observed fluorescence
was not the result of photo-oxidation of the dye (Figure 2.2). For intracellular nitric oxide
detection, cells were incubated with 1 µM DAF-FM for 20 min, 48 hrs after irradiation, as this
was found to be the peak time point for nitric oxide production (Figure 2.3). Cells were also
incubated with PBS only for 20 min to control for intracellular fluorescence from melanin
pigmentation and anthocyanins. Cells were detached using TrypLE and harvested in PBS
immediately after incubation with dye. Harvested cells were washed by centrifugation and
resuspended in PBS for flow cytometry analysis. Cells were sorted using a BD FACSCalibur
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Figure 2.2 Emission spectra of H2DCFDA 30 min after blue light exposure or dark treatment.
Excitation wavelength was 495 nm.
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Figure 2.3 DAF-FM fluorescence in UV-B-exposed ARPE-19 cells.
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flow cytometer, and intracellular fluorescence was measured using a 488 nm excitation laser and
530/30 nm emission bandpass filter. A total of 10,000 cells were counted per sample. Samples
were protected from light during handling. An example histogram of DAF-FM flow cytometery
results is shown in Figure 2.4. The shift towards increased fluorescence indicates the presence of
intracellular nitric oxide in the sample population.

Figure 2.4 Histogram of DAF-FM fluorescence versus cell counts in UV-B-treated ARPE-19
cells 24 hrs after irradiation.
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Study and Characterization of Aged Human Melanin and Melanin Degradation Products

Human melanin was isolated from young and aged donor eyes, and calf melanin was
isolated from calf eyes as previously described. Cells were pigmented with melanin granules or
black latex beads for this study. Pigmented cells were subjected to blue light or UV-B
irradiation and intracellular ROS and nitric oxide were detected as described in the previous
section. Melanin samples were characterized using MALDI-TOF mass spectrometry and
degraded synthetic melanin was characterized using molecular spectroscopy and ESI-MS. 1%
hydrogen peroxide was used as a blank for UV-Vis experiments with degraded synthetic
melanin.

Degradation of Synthetic Melanin

To degrade the pigment, synthetic melanin was reacted with 1% hydrogen peroxide. The
solution was stirred for 24 hrs until no solid particles remained and the solution was yellow in
color.

Electrospray Ionization Mass Spectrometry (ESI-MS)

For ESI conditions, capillary temperature was 200°C and spray voltage was set to 4.5 kV.
For MSn experiments, collision energy was set at 28%. Full spectra were collected between m/z
range of 150 and 1000 in positive ion mode. Samples were dissolved in a solution of 50:50
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methanol:water with formic acid and analyzed via direct infusion. Samples were analyzed in
triplicate to assess the reproducibility of the results.

Matrix Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry
(MALDI-TOF MS)
MALDI-TOF analysis was carried out using a Shimadzu MALDI-7090 TOF-TOF MS.
Samples were mixed with sinapinic acid matrix before loading onto MALDI target plate. One
µL of the melanin sample-matrix mixture was loaded on a steel MALDI plate (Shimadzu
Scientific, Fleximass targets TO-431R00) in triplicate. The sample-matrix mixture was allowed
to dry at room temperature. The MALDI mass spectra were acquired by scanning in positive ion
linear mode. Each sample was analyzed in triplicate to assess the reproducibility of the results.

Study of RPE Cell Immune Response on Extracellular Matrix Protein

Pigmented ARPE-19 cells were seeded onto RPE-derived extracellular matrix (ECM)
protein. ECMs were glycated as a means of stressing cells during attachment. The model
system was characterized to determine changes in cell attachment and cell viability to modified
ECMs. Figure 2.5 shows changes in unpigmented RPE cell morphology with attachment to
unmodified and glycated ECMs. Cells become elongated and more fibroblast-like in
morphology with attachment to glycated ECM, indicative of stress. Changes in IL-6 expression
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Figure 2.5 ARPE-19 cell morphology on protein substrate. A) Tissue-culture-treated plate (no
ECM), B) unmodified ECM C) glycolaldehyde-treated ECM, D) methylglyoxal-treated ECM.
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and secretion were monitored during and after attachment of pigmented RPE cells to respective
substrate.

RPE Derived Extracellular Matrices and ECM Glycation

ARPE-19 cells were maintained in complete media for 6-7 weeks. After this time, ECMcell samples were washed with PBS and incubated in 20 mM ammonium hydroxide solution for
20 min. Cells were gently washed away with PBS (five times) and samples were incubated in
PBS for 1 hr. ECMs were then washed two times with PBS and incubated with either 50 mM
glycolaldehyde in PBS, 50 mM methylglyoxal in PBS, or PBS only for 6 hrs. After glycation,
ECMs were gently washed five times with PBS and incubated for a minimum of 6 hrs in PBS.
After incubation, ECMs were washed two more times and allowed to dry prior to seeding. All
solutions were sterile filtered prior to use. Modifications are noted as GA for glycolaldehydetreated ECMs, MG for methylglyoxal-treated ECMs, or as unmodified ECM. No ECM denotes
tissue-culture-treated plate as attachment substrate.

Rate of Cell Attachment Assay

Cells were seeded onto ECMs at a density of 100,000 cells/mL. Aliquots of media were
removed from wells every 10 min after seeding. Cells in media suspensions were then counted
using a hemocytometer.
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Neutral Red Assay for Cell Viability and Lysosome Function

Twenty-four hours after seeding, media was removed and cells were washed with PBS.
Cells were then incubated for 2 hrs with a 10% Neutral Red solution in complete media, made
with a stock solution of 0.33% Neutral Red in PBS. The stock solution was sterile filtered prior
to use. After incubation, the solution was gently aspirated and cells were carefully washed with
PBS. Cells were solubilized in an ice-cold solution of 1% acetic acid in 50% ethanol.
Absorbance was measured at 540 nm.

MTT Assay to Measure Cell Attachment

MTT reagent was prepared at a concentration of 5 mg/mL in PBS and sterile filtered
prior to use. Cells were seeded with 500 µL of a 10% MTT in phenol red-free media solution
and incubated for 30 min. MTT-containing media was gently aspirated and formazan was
dissolved in 500 µL of DMSO. Absorbance was measured at 570 nm.

RNA Isolation and qPCR

Cells were harvested in TRIsure reagent and loaded onto a Direct-zol RNA Miniprep
Plus column. RNA was purified according to the manufacturer’s protocol. Reverse transcription
reactions were done using Moloney murine leukemia virus reverse transcriptase. Expression of
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IL-6 relative to GAPDH was assessed using the following primers: GAPDH, 5’CTCGACTTCAACAGCGACA -3’ (forward) and 5’- GTAGCCAAATTCGTTGTCATACC -3’
(reverse); IL-6, 5’-TCCAAAGATGTAGCCGCCC-3’ (forward) and 5’CAGTGCCTCTTTGCTGCTTTC (reverse).

ELISA

Nunc MaxiSorp ELISA plates in conjunction with a PeproTech human IL-6 ELISA kit
were used to quantify IL-6 levels in cell media. The assay was performed in accordance with the
manufacturer’s protocol. Absorbance of ABTS was measured as a reporter for IL-6.

Synthesis and Characterization of Liposomes for L-DOPA Delivery
Liposomes were prepared using the ethanol injection method. A 4:1 ratio of phosphatidyl
choline to cholesterol was dissolved 1 mL of ethanol; 0.5 mL of this mixture was injected into 10
mL of solution at 4.29 mL/hr with constant stirring. The final lipid concentration was 2.0
mg/mL. Argon gas was then bubbled through the mixture for 20 min, removing excess ethanol.
Liposomes were then extruded using 0.2 and 0.1 µm polycarbonate filters, with nitrogen pressure
maintained between 100-300 psi. Samples were filtered 10 times. Unencapuslated compounds
were removed from the solution by dialysis. Samples were dialyzed against PBS for 24 hrs at
4°C, protected from light. Final liposome solutions were protected from light and stored at 4°C
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until use. Solutions encapsulated using this method were 100 µM L-DOPA in pH 5 citrate
buffer, 100 µM fluorescein in PBS, or buffer only.

L-DOPA Encapsulation Efficiency
L-DOPA-encapsulated liposomes were lysed with 1% of a 0.1% Triton-X solution. The
mixture was vortexed for 30 secs and allowed to rest for 5 min. Dynamic light scattering was
performed to ensure vesicles were no longer intact. UV-Vis measurements were taken of the
lysed liposome solution and compared to the absorbance of a concentration-matched L-DOPA
solution. Percent encapsulation efficiency was determined by comparing the absorbance at λmax.
Figure 2.6 shows the absorbance spectra of L-DOPA in solution and lysed L-DOPAencapsulated liposomes. The average encapsulation efficiency of L-DOPA was 87 ± 2%.

Dynamic Light Scattering
Hydrodynamic diameter was measured by dynamic light scattering (DLS) on a
Brookhaven BI-200SM research goniometer and laser light scattering system (5mW He–Ne
laser, λ=632 nm) using CONTIN software. Liposomes were 146 ± 18 nm in diameter with
polydispersity of 0.237 ± 0.127 (mean ± std dev, n = 6).
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Figure 2.6 Absorbance spectra of L-DOPA in solution and lysed L-DOPA-encapsulated
liposomes.
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Liposome Uptake by ARPE-19 Cells Using Fluorescein Probe
Cells were incubated with 10% fluorescein-encapsulated liposomes in media or with
concentration-matched fluorescein directly in media. Control cells were fed buffer or bufferencapsulated liposomes. After overnight incubation, cells were washed three times with warm
PBS and detached using TrypLE. Cells were harvested in PBS and washed by centrifugation.
Cells were resuspended in PBS for flow cytometry analysis.

Study of L-DOPA and L-DOPA Oxidation Products

L-DOPA oxidation products were characterized using LC/MS, and structural predictions
for these compounds were done using Shimadzu Formula Predictor software. Oxidation
products were also collected for feeding to ARPE-19 cells and effects were evaluated in
comparison to L-DOPA supplements. Monitoring changes in cell viability assessed benefits of
liposomal delivery of L-DOPA to photo-stressed ARPE-19 cells.

Oxidation of L-DOPA
Partial oxidation of L-DOPA was done at pH 7.4 in ambient conditions for time periods
specified in Results. Full oxidation of L-DOPA was done at pH 10 under ambient conditions for
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specified time periods. Starting concentrations of 10 mg/mL were used for oxidation
experiments.

LC/MS Analysis of L-DOPA Oxidation Products

LC/MS analysis was performed using an LCQ Advantage mass spectrometer system with
a Surveyor LC pump and PDA detector. Separations were performed on a 100 mm x 3.0 mm
Kinetex C18 column. Mobile phase was 0.1% formic acid in MeOH (B) balanced with water.
Products were eluted using a gradient of 4 – 65% B (8-16 min), 65 - 70% B (16 – 19 min), 70 –
80% B (19 – 26 min), and 80 – 95% B (26 – 50 min) at a flow rate of 0.13 mL/min. Absorbance
was monitored at 280 and 320 nm. For ESI-MS conditions, capillary temperature was 200°C
and spray voltage was set to 4.5 kV. For MS/MS and MS3 experiments, collision energy was set
at 28%. Full spectra were collected between m/z range of 200-1000.

UV-C Rescue Assay with L-DOPA and L-DOPA Oxidation Products
After UV-C exposure, PBS was gently aspirated and cells were supplemented with 10
µM L-DOPA or matched starting material concentration of oxidation products in media. For
liposome experiments, encapsulated L-DOPA concentration was matched to L-DOPA
supplement given directly in cell media. Control cells were supplemented with vehicle or bufferencapsulated liposomes. Cells were incubated for either 1 day, 3 days, or 5 days with
supplement post irradiation.
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MTT Assay for Cell Viability

MTT reagent was prepared at a concentration of 5 mg/mL in PBS and sterile filtered
prior to use. After respective treatments, cells were incubated in 10% MTT in phenol red-free
media solution for 90 min. MTT-containing media was gently aspirated and formazan was
dissolved in 500 µL of DMSO. Absorbance was measured at 570 nm.

Lysosomal Membrane Permeability Assay
Cells were incubated with either 500 µM of L-DOPA or starting-material concentrationmatched oxidation products for 24 hrs. Media was aspirated and cells were washed twice with
warm PBS. Cells were incubated for 5 min with 0.5 µg/mL acridine orange in PBS or in PBS
only. Cells were then washed three times with warm PBS and detached using TrypLE. Cells
were harvested in PBS and washed by centrifugation. Cells were resuspended in PBS for flow
cytometry analysis. Intracellular fluorescence was measured using a 488 nm excitation laser and
530/30 nm emission bandpass filter or a 670 nm long pass emission filter.

Effects of Anthocyanin Supplements on RPE Cells and Characterization of Anthocyanin
Oxidation Products
The antioxidant effects of the anthocyanins, callistephin and oenin, were studied in bluelight-stressed ARPE-19 cells. Intracellular ROS production was determined and MTT assay
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was used to measure changes in mitochondrial redox activity, using the MTT procedure
previously described. The antioxidant capacity of these compounds was determined in solution
and the structures of callistephin and oenin oxidation products were elucidated using LC/MS.

Antioxidant Activity of Anthocyanins in Solution

To test the antioxidant activity of callistephin and oenin, 200 µM H2DCFDA in PBS
solutions were treated with H2O2 and respective anthocyanin. Samples were prepared in 24-well
plates; 1 µg/mL of anthocyanin was added to H2DCFDA solution prior to addition of H2O2. The
final concentration of H2O2 for tested samples was 3%. Fluorescence measurements were taken
immediately after the addition of H2O2. Measurements were taken using a BioTek Synergy-2
microplate reader using 485/20 nm excitation and 528/20 nm emission filters. Samples were
protected from light during handling.

Anthocyanin Oxidation with H2O2 for LC/MS Analysis

One µg/mL anthocyanin solutions were reacted in 3% H2O2 for 2 min. Reaction mixtures
were analyzed using LC/MS.
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LC/MS Analysis and MS Conditions

LC/MS analysis was performed using an LCQ Advantage mass spectrometer system with
a Surveyor LC pump and PDA detector. Separations were performed on a 100 mm x 3.0 mm
Kinetex C18 column. Products were eluted isocratically using 50% methanol in water with 0.1%
formic acid for 10 min followed by a linear gradient of 50-70% methanol in water with 0.1%
formic acid for 10 min at a flow rate of 0.13 mL/min. Absorption was monitored at 520 nm. For
ESI-MS conditions, capillary temperature was 200°C and spray voltage was set to 4.5 kV. For
MS/MS and MS3 experiments, collision energy was set at 25%. Full spectra were collected
between m/z range of 200-1000.

Data Analysis
For flow cytometery experiments, data was collected using CellQuest software and
analyzed using FlowJo software. Statistical data analysis was performed with GraphPad Prism
software using either a one-way or two-way ANOVA. P-values less than or equal to 0.05 were
considered significant. Experiments were performed in technical and biological triplicates.

CHAPTER 3

CHARACTERIZATION OF RPE MELANIN AND DEGRADED SYNTHETIC MELANIN
USING MASS SPECTROMETRY AND IN VITRO DIAGNOSTICS

Introduction

The retinal pigment epithelium (RPE) is a layer of retinal tissue pigmented by the
heterogeneous polymer, melanin, with eumelanin being the predominant form present in the RPE
(Ito et al, 2013; Sarna 1992). While the role of RPE melanin is not fully understood,
experimental evidence suggests that the pigment behaves as an antioxidant and photoprotectant
in the retina (Krol & Liebler, 1998; Seagle et al, 2006; Seagle et al 2005; Z. Wang et al, 2006a).
As a biological material, melanin possesses a number of beneficial characteristics to protect
tissue from oxidative stress and damage. These protective qualities have been attributed to
melanin binding redox-active metal ions, scavenging free radicals, and quenching reactive
oxygen species (ROS), in addition to being a UV-Vis photoprotectant (Hong & Simon, 2006;
Kaczara et al, 2012; Rozanowska et al, 1999; Sarna et al, 1985; Szpognicz et al, 2002;).
Previously, it has been shown that there is a significant decrease in melanin content in
the RPE with increasing age (Sarna et al, 2003). This observable loss of melanin with age may
be due to photodegradation of the pigment over time (Ito et al, 2013). Consequently,
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degradation of the polymer can result in changes to chemical behavior. Namely, the antioxidant
and photoprotective capacity of melanin is lost with these structural changes (Burke et al, 2011;
Zadlo et al, 2009; Zareba et al, 2006). It has even been found that photodegradation of melanin
under aerobic conditions yields hydroxyl radical formation (Korytowski et al, 1987; Korytowski
& Sarna, 1990), suggestive of tissue damage mechanisms in vivo. With increasing age there is
also an increase in the formation of melanolipofuscin in the retina (Feeney-Burns et al, 1990;
Feeney-Burns et al, 1984). The increased formation of this lipofuscin-melanin material may also
contribute to the observed loss of melanin with age.
A strong body of evidence has linked the pathogenesis of ocular diseases such as Agerelated macular degeneration (AMD) to chronic oxidative stress and inflammation in the retina
(Ambati et al, 2013; Jarrett & Boulton, 2012; Mitter et al, 2014). Studies have even associated
genetic variations in immune system factors to AMD, the best known example being variation in
complement factor H (CFH) protein (Edwards et al, 2005; Hageman et al, 2005; Haines et al,
2005; Klein et al, 2005). Dysfunctions in CFH can result in unregulated activation of the
complement pathway, leading to retinal pigment epithelial (RPE) cell inflammation via
upregulation of proinflammatory cytokines (Okemefuna et al, 2010).
In understanding the effects of age-related changes to the retina and the etiology of ocular
diseases such as AMD, it is necessary to examine and characterize changes to melanin with
increasing age and, importantly, how aged melanin mediates oxidative stress in the retina. In this
study, age-related changes to RPE human donor melanin samples are analyzed using MALDITOF mass spectrometry. Functional changes to melanin are assessed in vitro by monitoring the
production of intracellular reactive oxygen species (ROS) and nitric oxide in photo-stressed
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ARPE-19 cells, pigmented with calf melanin or aged human donor melanin. Additionally,
synthetic melanin is subjected to oxidative degradation by peroxide, and chemical changes are
characterized using molecular spectroscopy and ESI-MS. Chemical analysis of aged melanin
and degraded melanin samples in conjunction with biochemical assaying provides insight for
understanding biochemical interactions of the degraded pigment in the aging retina.

Results

MALDI-TOF MS Analysis of Human Donor Melanin

Melanosomes isolated from human donor RPE cells are shown in Figure 3.1. Samples in
Figure 3.1 were prepared at equal mg/mL concentrations. Tube A shows a sample from a 19year-old donor and tube B shows a sample from a 78-year-old donor. Tube A and tube B donors
had no history of ocular disease. Melanosomes in tube C were isolated from a 67-year-old donor
diagnosed with dry AMD. Qualitatively, the isolated melanosomes from the 67-year-old dry
AMD donor (tube C) appear lighter in color than the 78-year-old control donor (tube B) and both
of these sets of granules are significantly less colored than the isolated granules in tube A (19year-old donor). The solutions of samples from older donors (tubes B and C) also appear much
lighter than the solution in tube A; this is likely due to a loss of conjugation in the polymer due to
oxidative degradation and a concomitant decrease in higher molecular weight fragments. This
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Figure 3.1 Collected human donor RPE melanosome samples. A) 19-year-old-donor, no history
of ocular disease. B) 78-year-old-donor, no history of ocular disease. C) 67-year-old donor
diagnosed with dry AMD.

may be evidence that as the structural integrity of the melanin polymer is compromised with age,
the protective function is also diminished.
The m/z distribution of isolated human donor and calf melanosomes is shown in Figure
3.2. For MALDI-TOF analysis, melanin samples were prepared in a saturated solution of
sinapinic acid matrix in water. As melanin is a heterogeneous polymer, there is no exact m/z
assigned to the substance – this is particularly relevant for biological samples where a range of
values can be observed for different donors based on the degree of melanin polymerization and
composition of the melanosome bilayer. However, it is possible to infer compositional
information based on the m/z distribution of isolated melanosomes. Figure 3.2 compares the m/z
distribution of human donor melanin from the 19-year-old, 78-year-old, and 67-year-old samples
(referenced in Figure 3.1) and calf melanin and peroxide-treated calf melanin samples. Calf
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Figure 3.2 MALDI-TOF analysis of human donor melanin and calf melanin samples. Mass
distribution shifts toward lower m/z species with increasing donor age and with degradation of
calf melanin.
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melanin and 19-year-old human donor melanin samples favor species with a higher m/z range
compared to older age samples, suggesting melanin degradation with increasing age.
Additionally, the young melanin samples show a more characteristic aggregation of ions
in the 75,000 to 100,000 m/z range. Calf melanosomes were treated with peroxide to model
oxidative degradation of melanin. The m/z distribution of peroxide-treated calf melanin mirrors
the spectrum for the 67-year-old AMD sample, suggesting extensive degradation of the human
donor melanin. The spectrum for the 78-year-old donor sample does not have a broad out
distribution of ions as seen in the 67-year-old AMD and peroxide-treated calf melanin samples.
This may suggest that while there are signs of degradation to the pigment, these modifications
are not as extensive as those in melanin from a donor with a history of retinal disease. These
results suggest melanosome degradation in vivo with increasing age and may also suggest that
extensive oxidation degradation of melanin could be a factor in the development of retinal
diseases such as AMD.

Intracellular ROS Production in Pigmented ARPE-19 Cells with Photic Stress

ARPE-19 cells were pigmented with black latex beads, calf melanin, or human donor
melanin as described in Chapter 2. Black latex beads were used as a control for phagocytosis
and light absorption properties inherent to melanin granules. The generation of intracellular
ROS was measured using 2’,7’-dichlorodihydrofluorescein diacetate (H2DCFDA) as a probe.
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Inside the cell, H2DCFDA is oxidized to DCF by ROS. DCF fluorescence was detected by flow
cytometry and used as a measure for intracellular ROS production in stressed cells.

Figure 3.3a shows the production of ROS in calf melanin pigmented APRE-19 cells after
blue light irradiation. A significant increase in intracellular ROS was observed in unpigmented
cells after blue light treatment (p < 0.0001). Relative to unpigmented cells, RPE cells pigmented
with black latex beads showed a 10% decrease in intracellular ROS with dark treatment;
however, this decrease was not statistically significant. A 19% decrease in intracellular ROS
was seen in irradiated cells fed black latex beads versus irradiated unpigmented cells (p ≤ 0.05).
This significant decrease in ROS production may be due to light absorption by the beads. With
dark treatment, calf melanin pigmented cells produced significantly less intracellular ROS than
unpigmented cells with dark treatment (p ≤ 0.01), showing a 23% decrease. With blue light
irradiation, calf melanin pigmented cells produced significantly less ROS than both unpigmented
and black latex bead pigmented cells (p < 0.0001). The significant decrease in intracellular ROS
in calf melanin pigmented cells versus unpigmented cells under dark treatment or photic stress
suggests melanin provides additional protection to these cells beyond broadband absorption. In
UV-B-irradiated cells (Figure 3.3b), calf melanin pigmented cells show a 43% and 32% decrease
in ROS compared to unpigmented and black latex bead fed cells (respectively), suggesting
protective qualities of the pigment with higher energy wavelength irradiation.
Figure 3.4a shows intracellular ROS generation in blue-light-exposed ARPE-19 cells,
pigmented with human donor melanin. Cells were pigmented with human donor melanin pooled
from 72- and 74-year-old donors with no history of ocular disease. The donor melanin produced
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(a)

(b)

Figure 3.3 Intracellular ROS in calf melanin pigmented ARPE-19 cells subjected to a) blue light
irradiation or b) UV-B irradiation. *p ≤ 0.05, **p ≤ 0.01, ****p < 0.0001.
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(a)

(b)

Figure 3.4 Intracellular ROS in human donor melanin pigmented ARPE-19 cells. Melanin was
pooled from 72- and 74-year-old donors with no history of ocular disease. a) Blue-lightirradiated cells and b) UV-B irradiated-cells. P-values compared to unpigmented dark-treated
control unless otherwise indicated. **p ≤ 0.01, ****p < 0.0001.
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a significant fluorescence signal, which was subtracted from the overall DCF-melanin signal. In
dark-treated cells, neither black latex bead nor human donor pigmented groups showed a
significant difference in intracellular ROS production versus unpigmented cells. In the dark,
black latex bead fed cells produced 12% less ROS compared to human donor melanin pigmented
cells. With blue light irradiation, human donor pigmented cells had a 30% decrease in ROS
versus irradiated unpigmented cells (p ≤ 0.05); however, there was only a 4% difference between
irradiated black latex bead cells and human donor melanin cells. This slight decrease in
intracellular ROS production between black latex bead fed and human melanin fed cells suggests
the minor protective effects of aged melanin may be primarily due to remaining optical
properties of the pigment in response to blue light exposure. Figure 3.4b shows intracellular
ROS production in human donor melanin pigmented cells subjected to UV-B irradiation. With
UV-B exposure, human donor melanin pigmented cells show a 28% and 24% decrease in ROS
versus unpigmented and black latex bead pigmented cells, respectively, suggesting the presence
of aged human melanin in these cells provides less protection under photic stress with higher
energy photons compared to the effects of calf melanin pigmentation.

Intracellular Nitric Oxide Production in UV-B-Irradiated Pigmented ARPE-19 Cells

Cells were pigmented as previously described. The generation of intracellular NO was
measured using 4-amino-5-methylamino-2’,7’-difluorofluorescein diacetate (DAF-FM) as a
probe. Inside of the cell, DAF-FM is selectively oxidized by nitric oxide. Cells were dyed with
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DAF-FM 48 hrs after irradiation, as this was determined to be the peak time point for
intracellular NO production in response to UV-B exposure. DAF-FM fluorescence was detected
using flow cytometry and used as a measure for intracellular NO production in stressed cells.
Figure 3.5a shows intracellular NO production in calf melanin pigmented cells 48 hrs
after UV-B exposure. Calf melanin pigmentation in UV-B-treated cells results in a significant
decrease in intracellular NO versus both irradiated unpigmented and black latex bead fed cells (p
< 0.0001, p < 0.001). Dark-treated cells pigmented with calf melanin produced 30% less NO
compared to unpigmented cells and 24% less than black latex bead fed cells, suggesting baseline
antioxidant activity specific to nitric oxide.
Figure 3.5b shows the results for intracellular NO production in human donor melanin
pigmented cells 48 hrs after UV-B exposure. The fluorescence signal from human donor
melanin was subtracted from the overall DAF-FM-melanin fluorescence signal. With
irradiation, intracellular NO production increases in human donor melanin pigmented cells by
61% compared to irradiated unpigmented cells and by 41% compared to irradiated black latex
bead fed cells. This relative increase in NO suggests that aged human melanin functions as a
pro-oxidant in UV-B-treated RPE cells, an effect not observed with calf melanin pigmentation.
Additionally, there is no evidence of baseline antioxidant activity specific to NO as observed in
dark-treated cells pigmented with calf melanin (Figure 3.5a). In the dark-treated group in Figure
3.5b, human donor melanin pigmentation does not result in a decrease in intracellular NO
compared to unpigmented and black latex bead fed cells.
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(a)

(b)

Figure 3.5 Intracellular NO in UV-B-treated pigmented ARPE-19 cells 48 hrs after exposure. a)
Calf melanin pigmented cells and b) Human donor pigmented cells. Donor melanin was pooled
from 72- and 78-year-old donors with no history of ocular disease. P-values compared to
unpigmented dark-treated control unless otherwise indicated. *p ≤ 0.05, **p ≤ 0.01, ***p <
0.001, ****p < 0.0001.
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(a)

(b)

Figure 3.6 Absorbance and steady-state fluorescence spectra peroxide-treated synthetic melanin.
a) Appearance of an absorbance maximum at 325 nm is observed in peroxide-treated synthetic
melanin product. b) Fluorescence excitation and emission spectra of oxidized synthetic melanin.
Peaks are approximately at 420 and 525 nm.
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Characterization of Peroxide-treated Synthetic Melanin

Synthetic melanin was subjected to oxidative degradation by treatment with hydrogen
peroxide. Figure 3.6a shows the absorption spectra of untreated and peroxide treated synthetic
melanin. Untreated synthetic melanin absorbs across the UV spectrum, with a slight increase
around 300 nm. The treatment of synthetic melanin with hydrogen peroxide resulted in the
formation of a yellow product. This product has an absorbance maximum at 325 nm and absorbs
more intensely in the blue light region than undegraded synthetic melanin. Additionally, this
degradation product shares an absorbance maximum with the melanin monomer 5’,6’dihydroxyindole carboxylic acid (DHICA). Figure 3.6b shows the steady-state fluorescence
spectra of degraded synthetic melanin. The degradation product has an excitation wavelength
maximum of 420 nm and an emission wavelength of 525 nm. Emission spectra were collected
using a 450 nm excitation wavelength to probe the interaction of degraded melanin with blue
light.
The peroxide-treated synthetic melanin solution was then analyzed using ESI-MS. The
MS spectrum up to m/z 550 and the MS/MS and MS3 spectra are shown in Figure 3.7a. The
most abundant ion in degraded synthetic melanin samples had a m/z 210. Fragmentation of this
ion resulted in a neutral loss of 42 amu. MS3 fragmentation resulted in a neutral loss of 44 amu.
Figure 3.7b shows the proposed starting material for the m/z 210 oxidation product.
DHICA has a m/z 194 and the addition of 16 amu would result in a species with m/z 210,
suggesting partial oxidation of DHICA. This proposal for the m/z 210 product is also consistent
with the shared characteristic absorbance at 325 nm of the degraded synthetic melanin solution
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(a)

(b)

Figure 3.7 MS, MS/MS, and MS3 spectra of peroxide treated synthetic melanin. a) Oxidative
degradation of synthetic melanin yields a product with m/z 210 and a product with m/z 281. b)
Structure of melanin monomer 5’6’-dihydroxyindole carboxylic acid (DHICA) with m/z 194.
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and DHICA, respectively. The proposed structure for the m/z 210 product could be confirmed in
future studies by NMR or elemental analysis of the purified product.

Discussion

RPE cells play a crucial role in maintaining vision, and the deterioration of these cells has
been implicated in the pathogenesis of retinal disease. Due to high metabolic activity and
residing in a highly oxidative environment, RPE cells are prone to chronic oxidative stress with
advancing age. The accumulation of metabolites that inhibit lysosomal function, such as
lipofuscin, can promote downstream oxidative stress and chronic inflammation (Hong & Simon,
2006; Rozanowska et al, 1999; Sarna et al, 1985). With increasing age, there is also an
observable decrease in the RPE pigment, melanin (Burke et al, 2011; Sarna et al, 2003; Zadlo et
al, 2009). Given that RPE cells are capable of expressing and secreting cytokines and other
immune response factors, it is possible that melanin-derived metabolites can be recognized as
damage-associated molecular patterns (DAMPs), leading to immune response activation and
inflammation (Feeney-Burns et al, 1990; Korytowski et al; 1985; Sarna et al, 1986).
Using in vitro modeling, the presented work has probed melanin reactivity in photostressed human RPE cells and gives qualitative insight to age-related changes to RPE melanin. It
has been proposed that chemical degradation of melanin is primarily responsible for the observed
loss of the RPE pigment with age, with blue light being a contributing factor (Sarna et al, 2003).
The trends presented in Figure 3.2 suggest that the peroxide-facilitated degradation of calf
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melanin produces melanin that follows similar m/z shifts as aged human donor melanin. With
increasing age, the human donor melanin spectra shift toward lower m/z species, as observed
with peroxide-treated calf melanin. In the case of the 67-year-old dry AMD sample, the shift
was more pronounced compared to the 19-year-old and calf melanin samples. These trends
suggest oxidative degradation of RPE melanin with increasing age and possible implications for
melanin degradation in the progression of retinal disease. The biological consequences of these
structural changes to RPE melanin can lead to tissue damage via depletion of the protective
characteristics of undegraded melanin. Cytoprotection of RPE cells by melanin is the result of
the free radical scavenging abilities, making the pigment an effective antioxidant and
photoprotectant (Burke et al, 2011; Rozanowska et al, 1999; Z. Wang et al, 2006a).
Functional changes to RPE melanin were determined by measuring intracellular ROS and
nitric oxide production in photo-stressed ARPE-19 cells, pigmented with either calf melanin or
aged human donor melanin. ARPE-19 cells pigmented with calf melanin show significant
protection against blue-light-induced intracellular ROS production compared to unpigmented
and black latex bead pigmented cells (Figure 3.3a). Even with dark treatment, there is evidence
for baseline protection against ROS generation in calf melanin pigmented cells versus
unpigmented cells. When pigmented with aged human donor melanin, ARPE-19 cells are less
protected against blue light photic stress (Figure 3.4a) compared to calf melanin pigmented cells.
With dark treatment, human donor melanin pigmented cells do not confer a significant decrease
in intracellular ROS versus control groups. With blue light irradiation, human donor melanin fed
cells generated ROS within the range of black latex bead fed cells. While light absorption
qualities may still be present in aged human donor melanin, progressive degradation of the
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pigment may explain waning antioxidant qualities. A similar trend has been observed in ARPE19 cells fed aged human donor melanin and the blue light photosensitizer A2E (Z. Wang et al,
2006a). The decline in antioxidant capabilities of these cells translated into decreased cell
viability and increased A2E oxidation. Coupled to our observations, blue-light-mediated damage
in RPE cells is most likely due to lipofuscin absorbance, not melanin (Sparrow et al, 2000).
In the eye, wavelengths of light below 390 nm are unable to reach the retina (Dillon et al,
1999; Gaillard et al, 2000). While UV-B radiation cannot reach the retina, it has been
established that UV-B has an immunosuppressive affect on exposed tissue (Gallo & Bernard,
2014; Schwarz et al, 2004; Schwarz et al, 2011; Sreevidya et al, 2010). UVB-initiated
immunosuppression has been largely attributed to the formation of cyclobutane pyrimidine
dimers (CPDs) in DNA (Kripke et al, 1992). Interestingly, it has been suggested that
chemiexcitation may be responsible for CPD formation in pigmented cells via the formation of
peroxynitrite in proximity to melanin (Premi et al, 2015). Exposing cells to UV-B can generate
the reactive species for the proposed mechanism. With UV-B stress, calf melanin maintained a
significant degree of protection versus unpigmented cells (Figure 3.3b). Interestingly,
pigmentation with human donor melanin did provide significant protection when cells were
exposed to UV-B radiation, compared to both unpigmented and black latex bead fed cells
(Figure 3.4b). Forty-eight hours after exposure, intracellular nitric oxide production was
significantly inhibited in calf melanin pigmented cells compared to unpigmented and black latex
bead fed cells (Figure 3.5a). In human donor melanin pigmented cells, a pro-oxidant effect was
observed in response to UV-B. Increased levels of nitric oxide were present in cells pigmented
with human donor melanin compared to control cells.
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Past studies have suggested there is a structural dependency of melanin, specifically
eumelanin, on ROS scavenging (Korytowski et al, 1985; Sarna et al, 1986). In these cases, it is
stipulated that the structural integrity of 5,6-dihydroxyindole subunits must be maintained to
preserve ROS scavenging in melanin polymers. More recently, it has been found that photooxidation of synthetic melanin can result in structural cross-linking (Ito et al, 2013). Pyrrole
derivatives identified as markers of eumelanin cross-linking were found in blue-light-exposed
bovine RPE melanosomes and in human RPE cells, suggesting age-related oxidative
modifications to RPE melanin. Additionally, it has been shown that the UVA-induced oxidation
product of 5,6-dihydroxyindole-2-carboxylic acid (DHICA), indole-5,6-quinone-2-carboxylic
acid, can react with ROS to form endoperoxide and other reactive intermediates (Ito et al, 2016).
It was found that cleavage of indole-5,6-quinone-2-carboxylic acid ultimately leads to the
formation of pyrrolic moieties previously implicated as markers of melanin degradation. In the
present work, oxidative degradation of synthetic melanin yields a singly charged species with
m/z 210 (Figure 3.7a). MS/MS of the 210 ion resulted in a loss of 42 amu, yielding an ion with
m/z 168. Typically, this neutral loss corresponds to the loss of an acetyl group from an aromatic
ring. Alternatively, loss of 42 amu from m/z 210 may be due to ring cleavage under these
experimental conditions. The MS3 spectrum shows a neutral loss of 44 amu from m/z 168. The
absorbance maximum of the oxidized melanin solution has the same absorbance maximum as
DHICA. The addition of 16 amu to the m/z of DHICA (Figure 3.7b) would result in a species
with m/z 210, so it is possible that the m/z 210 product is oxidized DHICA. It is also possible
that the m/z 210 product represents partial oxidation and cleavage of the melanin polymer, or
formation of an epoxide species.
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A previous study compared the fluorescent properties of oxidized synthetic melanin and
bovine melanosomes (Kayatz et al, 2001). The results suggested that oxidation of the
melanosome lipid bilayer does not significantly contribute to the steady state fluorescence of
oxidized melanosomes. Additionally, it was observed that aged human donor melanin fluoresces
in the green wavelength range, as is observed in the synthetic melanin degradation product
(Figure 3.6b). It is possible that oxidized DHICA plays a key role in the formation of products
such as melanolipofuscin that increase with increasing age and can possibly trigger inflammation
in the RPE. In this respect, products formed from the oxidative degradation of melanin may
contribute to the pathogenesis of diseases such as AMD. Additionally, studies have also
observed pro-oxidant behavior in photobleached melanosomes (Korytowski et al, 1987; Zadlo et
al, 2009; Zareba et al, 2006), further implying the role of oxidized melanin in promoting the
disease state.
This study characterizes the effects and changes to melanin over time by monitoring
intracellular ROS and nitric oxide production in photo-stressed RPE cells pigmented with either
calf melanin or aged human donor melanin. Chemical changes to RPE melanin with age, such as
oxidation, were observed using mass spectrometry and spectroscopic methods. RPE
melanosomes lose protective antioxidant properties with age and undergo chemical changes that
reflect degradation of the polymer-organelle complex. The presented evidence supports the
hypothesis that degraded melanin in the RPE may contribute to the progression of retinal disease
by decreasing the antioxidant capacity of the retina and participating the formation of
inflammatory components such as melanolipofuscin.

CHAPTER 4

CALF MELANIN IMMUNOMODULATES RPE CELL ATTACHMENT TO
EXTRACELLULAR MATRIX PROTEIN

Introduction

The retinal pigment epithelium (RPE) is a specialized layer of postmitotic cells that form
tight junctions between the choroid and the neural retina, regulating passage of nutrients and
signaling factors from the bloodstream to the ocular space (Zinn & Marmor, 1979).
Consequently, the blood-retina barrier makes the eye an immune privileged site (Detrick &
Hooks, 2010; R. Zhou & Caspi, 2010). In vivo, RPE cells adhere to Bruch’s membrane, a
multilayered tissue composed of extracellular matrix (ECM) proteins. Bruch’s membrane rests
between the RPE and choroid and not only serves as a substrate for RPE cell attachment but also
as a vessel wall and structural component of the posterior segment of the eye (Curcio et al,
2013). The integrity of the RPE is highly dependent on cell attachment to Bruch’s membrane,
and age-related modifications to these ECM proteins can disrupt RPE cell attachment and
function (Glenn et al, 2009; Sun et al, 2007).
A defining characteristic of RPE cells is pigmentation via the heterogeneous polymer
eumelanin. The role of melanin in the RPE is not fully understood; however, evidence suggests
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that undegraded melanin protects RPE cells from oxidative and photo-oxidative damage and
serves as an endogenous protective component (Burke et al, 2011; Seagle et al, 2006; Seagle et
al, 2005; Z. Wang et al, 2006a). Melanogenesis is considered to be a prenatal event in the RPE,
as tyrosinase, the rate-limiting enzyme in melanin biosynthesis, is absent after gestation (Carr &
Sigel, 1979; Sarna, 1992; Smith-Thomas et al, 1996). In this respect, fully differentiated RPE
cells contain a fixed quantity of mature melanosomes throughout an individual’s lifetime. This
speculation is supported by the observed loss of RPE melanin with age (Sarna et al, 2003). This
loss of melanin can be attributed to photo-induced degradation of the polymer, resulting in
structural changes and compromised antioxidant behavior (Ito et al, 2016; Ito et al 2013; Zadlo
et al, 2009; Zareba et al, 2006). In juvenile pigmented rats, RPE melanin granules were shown
to be more resistant to light damage compared to melanin in adult rats (Polosa et al, 2017),
suggesting a decline in melanin function with age. In human RPE cells, the presence of
melanosomes delayed cell death with photic stress, but this delay was not observed in black latex
bead fed cells (Zareba et al, 2014). This evidence suggests that melanosome protection is not
restricted to light absorbance or granule functionality. Given the change in behavioral
characteristics with degradation, it is possible that melanin in the RPE can participate in
regulatory functions of the cell, behaving as a signaling agent.
Another key feature of RPE cells is the ability to express and secrete a variety of
signaling factors, namely cytokines (Benson et al, 1992; Detrick & Hooks, 2010; Elner et al,
1992; R. Zhou & Caspi, 2010). Given that the eye is an immune privileged site, this function of
the RPE regulates immune response and inflammation in the retina. Expression and secretion of
cytokines by RPE cells may also play a role in maintaining the structural and functional integrity
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of these cells, with specific regard to cell adhesion. In particular, the cytokine interleukin-6 (IL6) may be a necessary factor in RPE cell adhesion to ECM proteins. Evidence shows that IL-6
promotes cell attachment and migration in a variety of adherent cell lines on various protein
substrates (Hsu and Chung, 2006; Jovanovic & Vicovac, 2009; Nishida et al, 1992).
With age, there are observable nonenzymatic modifications to ECM proteins, including
nitration and glycation. In particular, accelerated glycation and consequent formation of
advanced glycation end products (AGEs) correlates with symptoms and progression of chronic
disease (Thornalley 1999; Baynes 2001). In the case of diabetes, accelerated formation of AGEs
is a result of the disease state itself and causes additional health complications (Basta et al, 2004;
Monnier et al, 1992). With regard to the eye, increased accumulation of AGEs has been
identified in the Bruch’s membrane-RPE space of age-related macular degeneration (AMD)
donor tissue, implicating the role of AGEs in AMD pathogenesis (Glenn et al, 2009; Handa et al,
1999; Ishibashi et al, 1998).
Modifications to Bruch’s membrane proteins have been shown to disrupt receptor-ligand
interactions between cells and ECM substrate. These disruptions induce transcriptional and
translational changes, an example being the upregulation of the angiogenic factor VEGF, a key
component in the pathogenesis of wet AMD (Fields et al, 2015; Howes et al, 2004; Ma et al,
2007; Tian et al, 2005). Evidence also suggests that pigment epithelium-derived factor (PEDF)
is regulated by RPE melanin. The down regulation of PEDF secretion due to lack of melanin
may link the pathogenesis of AMD with decreasing RPE pigmentation with age (Brilliant et al,
2016; Lopez et al, 2008). ECM-induced transcriptional changes can be exploited to probe
signaling factors necessary for RPE cell adhesion in a model system by utilizing a synthetically
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glycated ECM substrate. In this study, in vitro modeling is used to investigate the role of IL-6 in
RPE cell adhesion to RPE-derived extracellular matrix proteins. Importantly, the role of
pigmentation in modulating RPE cell immune response and attachment to these proteins is also
considered.

Results

Rate of Unpigmented RPE Cell Attachment to ECM Substrates and Cell Viability

The rate of ARPE-19 cell attachment to protein substrate was evaluated by counting
unattached cells in media suspension at 10-minute intervals after seeding (Figure 4.1). Over the
course of 1 hr a significant decrease in the rate of cell attachment was observed in cells seeded
onto glycated matrices versus unmodified ECM (p < 0.0001). No significant difference was
observed in the number of unattached cells present in cell suspensions from unmodified matrices
and no ECM groups; however, the average number of unattached cells over the course of 1 hr
after seeding onto an unmodified matrix was 24% lower than cells seeded onto no ECM. 24 hrs
post seeding, there is no significant change in cell viability as determined by the Neutral Red
assay (Figure 4.2). Briefly, viable cells will take up Neutral Red dye via active transport to
lysosomes. An 8% increase in the dye-loaded population is seen in cells seeded onto an
unmodified matrix versus no ECM control.
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Figure 4.1 Rate of unpigmented ARPE-19 cell attachment to glycated ECMs.

Figure 4.2 Unpigmented ARPE-19 cell viability as determined using the Neutral Red assay.
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Effect of ECM Substrate on IL-6 Expression in RPE Cells

Relative IL-6 expression was determined using qPCR. IL-6 expression was monitored
during cell attachment (30 min after seeding) and after attachment of the seeded population (24
hrs). To test if any detectable changes in IL-6 expression would be observed in our model
system, confluent unpigmented cells were used. Significant induction of IL-6 expression was
observed in unpigmented ARPE-19 cells seeded onto unmodified ECM after 30 min (Figure
4.3a), relative to cells seeded onto no ECM or glycated matrices (p < 0.001, p ≤ 0.05, and p <
0.01). Figure 4.3b shows that 24 hrs after seeding there is a significant decrease in IL-6
expression in unpigmented cells attached to either unmodified or glycated ECMs (88%, 96%,
and 92%, respectively) versus No ECM (p ≤ 0.05, p < 0.001, and p < 0.01).
The effect of pigmentation on IL-6 expression was evaluated in conjunction with ECM
substrate modifications. Latex bead pigmented cells were included as a control for granule
phagocytosis. In the pigmentation experiments, cells were first grown to confluency and then
pigmented over the course of several days, resulting in four additional days of plate attachment
prior to detachment for ECM seeding compared to cells used for previously discussed
experiments. Additionally, only methylglyoxal-treated matrices were used for the glycated ECM
group, as previously discussed results suggest a similar effect on cell behavior with either
glycating agent.
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Figure 4.3 Relative IL-6 expression in unpigmented ARPE-19 cells a) 30 min after seeding and
b) 24 hrs after seeding. *p ≤ 0.05; **p < 0.01, ***p < 0.001. GA denotes glycolaldehyde-treated
ECM and MG denotes methylglyoxal-treated ECM.
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Figure 4.4a shows relative IL-6 expression in pigmented ARPE-19 cells 30 min after
seeding onto respective protein substrate. Pigmentation with calf melanin yields a significant
increase in IL-6 expression versus unpigmented and latex bead pigmented controls regardless of
protein substrate (p < 0.0001). Interestingly, IL-6 expression significantly decreases in
unpigmented cells 30 min after seeding onto unmodified ECM and glycated ECM versus no
ECM by 70% and 63%, respectively. This shift in trend compared to IL-6 expression in Figure
3.3a may be due to extended attachment time while cells were supplemented with granule
suspension vehicle. ECM glycation decreases IL-6 expression in latex bead and calf melanin
pigmented cells (versus unmodified ECM) 30 min after seeding.
Twenty-four hours after seeding there is a significant decrease in IL-6 expression in calf
melanin pigmented cells compared to unpigmented and latex bead pigmented control cells
regardless of protein substrate (Figure 4.4b). Unpigmented cells show a significant increase in
IL-6 expression when seeded onto either an unmodified ECM (by 118%; p < 0.01) or glycated
ECM (by 85%; p ≤ 0.05) versus no ECM. Again, this shift in trend versus results in Figure 3.3b
may be due to extended attachment time while cells were supplemented with granule suspension
vehicle. Table 4.1 highlights the trends in relative IL-6 expression in pigmented ARPE-19 cells
30 min and 24 hrs after seeding.
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Figure 4.4 Relative IL-6 expression in pigmented ARPE-19 cells. a) 30 min after seeding onto
ECMs and b) 24 hrs after seeding onto ECMs. *p ≤ 0.05, **p < 0.01, ***p < 0.001, ****p <
0.0001. MG denotes methylglyoxal-treated ECM.
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Table 4.1 Relative change in IL-6 expression in pigmented ARPE-19 cells a) 30 min after
seeding and b) 24 hrs after seeding. Trends are relative to unpigmented cells seeded onto no
ECM.

(a)
Unpigmented
Black latex beads
Calf melanin
(b)
Unpigmented
Black latex beads
Calf melanin

No ECM
êé
é
(NS)
é (p < 0.0001)
No ECM
ê
(NS)
ê (p < 0.0001)

Unmodified ECM
ê (p < 0.001)
é
(NS)
é (p < 0.0001)

Glycated ECM
ê (p < 0.01)
ê
(NS)
é (p < 0.0001)

Unmodified ECM
é (p < 0.01)
é
(NS)
ê (p < 0.0001)

Glycated ECM
é (p ≤ 0.05)
é
(NS)
ê (p < 0.0001)
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IL-6 Secretion in RPE Cells Seeded onto ECM Substrates

IL-6 secretion was measured using an ELISA. IL-6 secretion was measured during cell
attachment (30 min after seeding) and after attachment of the seeded population (24 hrs).
Figure 4.5a shows relative IL-6 secretion in pigmented ARPE-19 cells 30 min after seeding.
Pigmented cells seeded onto glycated ECM show an insignificant increase in IL-6 secretion
ranging from a 1% increase in latex bead pigmented cells to a 4% increase in calf melanin
pigmented cells versus respective no ECM controls. A significant 26% increase in IL-6
secretion is seen in unpigmented cells seeded onto glycated ECM versus unpigmented No ECM
control (p ≤ 0.05) and a 23% increase compared to unpigmented cells seeded onto unmodified
matrix (p ≤ 0.05). No significant difference in IL-6 secretion was observed in unpigmented
versus pigmented cells, regardless of substrate.
Twenty-four hours after seeding, calf melanin pigmented cells seeded onto an unmodified
matrix show a 7% increase in IL-6 secretion compared to unpigmented cells seeded onto an
unmodified ECM (Figure 4.5b). An 11% increase in IL-6 secretion is observed in calf melanin
pigmented cells versus unpigmented cells seeded onto glycated ECM and a 3% increase is seen
comparing calf melanin pigmented cells to unpigmented cells seeded onto no ECM. Modest
increases in IL-6 secretion were observed in calf melanin pigmented cells versus unpigmented
cells; however, this trend was not statistically significant. Table 4.2 highlights the trends in
relative IL-6 secretion 30 min and 24 hrs after seeding.
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Figure 4.5 Relative IL-6 secretion in pigmented ARPE-19 cells. a) 30 min after seeding onto
ECMs and b) 24 hrs after seeding onto ECMs. *p ≤ 0.05, **p < 0.01. MG denotes
methylglyoxal-treated ECM.
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Table 4.2 Relative change in IL-6 secretion in pigmented ARPE-19 cells a) 30 min after seeding
and b) 24 hrs after seeding. Trends are relative to unpigmented cells seeded onto no ECM.

(a)
Unpigmented
Black latex beads
Calf melanin
(b)
Unpigmented
Black latex beads
Calf melanin

No ECM
é
ê

(NS)
(NS)

Unmodified ECM
é
(NS)
é
(NS)
ê
(NS)

Glycated ECM
é (p ≤ 0.05)
é
(NS)
é
(NS)

(NS)
(NS)

Unmodified ECM
é
(NS)
ê
(NS)
é
(NS)

Glycated ECM
no change
é
(NS)
é
(NS)

No ECM
ê
é
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Pigmented RPE Cell Attachment to ECM Substrate 30 min After Seeding

MTT was used to evaluate the relative efficiency of pigmented ARPE-19 cell attachment
to protein substrate 30 min after seeding (Figure 4.6). Due to additional variables, MTT reagent
was used for quantifying cell attachment versus manual cell counts. Calf melanin pigmented
cells show a significant increase in attachment to no ECM and unmodified ECM compared to
unpigmented cells with respective 212% and 138% increases. When seeded onto glycated ECM,
calf melanin pigmented cell populations showed 99% increased attachment versus unpigmented
cells seeded on glycated ECM. Both calf melanin and latex bead pigmented cells show a
decrease in attached population when seeded onto an unmodified matrix versus no ECM while
unpigmented cells show a 34% increase in attached population. For all pigmentation groups,
seeding onto a glycated ECM resulted in decreased population attachment after 30 min versus no
ECM and unmodified ECM groups, respectively.

Discussion

IL-6 expression was evaluated in this study not only due to implications for this cytokine
in mediating a proinflammatory disease state, but also because it has been shown to be a
necessary component for the attachment of cell lines such as human colorectal carcinoma cells,
trophoblasts, and corneal epithelial cells in vitro (Hsu & Chung, 2006; Jovanovic & Vivovac et
al, 2009; Nishida et al, 1992).
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Figure 4.6 Attachment of pigmented ARPE-19 cells to matrices 30 min after seeding determined
by MTT conversion to formazan. *p ≤ 0.05, ***p < 0.001. MG denotes methylglyoxal treated
ECM.
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The results of the presented work suggest that IL-6 is induced in ARPE-19 cells during
attachment to unmodified ECM proteins. Notably, this induction is not present in cells attaching
to glycated matrices or poly-D-lysine-coated-tissue-culture-treated plates (no ECM), where cell
attachment is delayed in response to substrate. Twenty-four hours after seeding, IL-6 expression
levels decrease in cells attached to ECMs, suggesting down regulation after attachment. When
unpigmented ARPE-19 cells are seeded onto protein substrate after prolonged attachment to a
previous plate, the trend in IL-6 expression shifts, reflecting low levels of expression 30 min
after seeding and increased levels 24 hrs after seeding. The dependency of IL-6 expression in
unpigmented ARPE-19 cells on the culture time period of these cells may have implications for
the role of IL-6 in retinal development versus maintenance of cell attachment in a postnatal state.
Interestingly, pigmentation has been induced in post-confluent ARPE-19 cells challenged with
A2E and rod outer segments (Poliakov et al, 2014). The formation of lysosomal melanin in
these cells was accompanied by increased expression of premelanosomal factors, namely
PMEL17 and TYRP1. De novo synthesis of melanin-like material in this system may suggest
engagement of a protective mechanism in response to stress.
Numerous studies have demonstrated that RPE cells play a key role in local immune
response in the posterior segment of the eye, and it is suggested that the main purpose of these
cells is to down regulate immune response and suppress inflammatory factors that may facilitate
tissue damage (Hook et al, 2008; Ikeda et al, 2006). Early studies investigating cytokine
secretion in RPE cells found that substantial IL-6 secretion could be induced via stimulation with
cytokines such as IL-1β (Benson et al, 1992; Planck et al, 1992). These studies were performed
with RPE cells from human donor eyes of unspecified age, using both subcultured and primary
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cell populations. Given this evidence, it is possible that activated RPE cells may enhance a
proinflammatory environment. A few studies suggest that IL-6 may play a regenerative role in
model ocular systems, namely behaving as a photoreceptor neuroprotectant against retinal-RPE
separation and as a mediator of inflammatory stimulated optic nerve regeneration (Chong et al,
2008; Leibinger et al, 2013).
Implications for the role of immune regulation in AMD have arisen from a body of
evidence proposing that polymorphisms in the innate immune system factor, Complement-H,
lead to increased statistical risk for developing AMD (Edwards et al, 2005; Haines et al, 2005;
Klein et al, 2005). The resulting dysfunction and constant activation of the complement system
can result in inflammation. Analysis of drusen deposits from donor AMD patients have shown
an accumulation of C-reactive protein components, suggesting mediation of or by these
inflammatory factors in AMD (Anderson et al, 2002; Hageman et al 2005; Hageman et al,
1999). Interestingly, significantly elevated levels of cytokines were found in the aqueous humor
of wet AMD donor eyes, with IL-6 being one of the components (Jones et al, 2012).
Given the loss of RPE melanin with age (Sarna et al, 2003) and decrease in protective
characteristics of the pigment with photodegradation (Ito et al, 2016; Ito et al, 2013; Zadlo et al,
2009; Zareba et al, 2006) coupled to observations implicating a role for immune-regulation in
ocular disease, it is of interest to probe the possible connections between pigmentation in the
RPE and immune regulation, using attachment to glycated ECM proteins as a stressor and
relevant age-related modification. In the presented model system, RPE cells are repigmented via
phagocytosis of melanin granules. Tyrosinase activity has been reported in RPE cells that were
fed rod outer segments or latex beads, suggesting phagocytosis can induce enzymatic activity
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(Julien et al, 2007; Schraermeyer et al, 2006). Differentiation of retinal stem cells in vitro has
resulted in RPE-like cells that can produce various-stage melanosomes (Aruta et al, 2010). The
prospect of inducing melanogenesis in RPE cells in vitro has implications for molecular studies
surrounding melanosome development. With regard to the aging retina, melanin biosynthesis
may not play such a critical role in evaluating functional effects of aged melanin, as this
enzymatic machinery may not be active in the same operative capacity postnatal.
Repigmentation of ARPE-19 cells allows for selective addition of melanin and granule types to
cells. Cells can be repigmented with aged human donor melanin or latex beads as control for
phagocytosis. The downstream effects of specific melanin types residing in RPE cells can be
evaluated in this system.
Glycation of extracellular matrix (ECM) proteins in Bruch’s membrane is a signature of
ocular aging and progression of disease state, with specific regard to Age-related macular
degeneration (AMD); (Glenn et al, 2009; Handa et al, 1999; Ishibashi et al, 1998). Compromise
to the structural integrity of Bruch’s membrane basal lamina consequently leads to detachment of
retinal pigment epithelial (RPE) cells, resulting in vision loss. Using human donor Bruch’s
membrane samples, it has been shown that aging of Bruch’s membrane can inhibit the ability of
RPE cells to phagocytize rod outer segments. Nonenzymatically nitrated RPE-derived ECMs
had an analogous effect on RPE cell phagocytosis, further supporting that age-related changes to
Bruch’s membrane protein play a role in AMD pathogenesis (Sun et al, 2007). In the present
study, in vitro modeling was used to characterize changes in ARPE-19 cell attachment to
glycated or unmodified RPE-derived ECMs and to assess immune response. ECM glycation
with either glycolaldehyde or methlyglyoxal delayed the rate of cell attachment to the modified
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protein substrate; however, the degree of glycation was not severe enough to inhibit cell
viability. The efficacy of attachment to tissue-culture-treated plates (no ECM) was also
evaluated to compare and determine ARPE-19 cell response to contact with unmodified ECM
proteins. While there was no significant difference in the rate of RPE cell attachment to no ECM
versus an unmodified matrix, there were significant differences in immune response of these
cells when the substrate was ECM protein.
The observed increase in population of attached calf melanin pigmented cells relative to
unpigmented cells may suggest a necessary role for melanin in RPE cell attachment.
Additionally, the concurrent increase in IL-6 expression in pigmented cells 30 min after seeding
may implicate a role for the cytokine in RPE cell attachment, mediated by pigmentation. The
effects of the latex bead fed control cells were modest in comparison to calf melanin pigmented
cells, suggesting that the chemical composition of phagocytized granule plays a key role in
signaling and regulation of inflammatory response. Additionally, IL-6 secretion showed little
fluctuation between pigmentation groups in response to ECM modifications. In comparison to
IL-6 expression, it is possible that in this model system extracellular IL-6 does not play as
influential a role in cell attachment and that the cytokine primarily functions as a component of
intracellular signaling for the process.
In this work, pigmentation-mediated cytokine activity was monitored in ARPE-19 cells
on various protein substrates in vitro. Relative IL-6 expression during and after attachment to
extracellular matrix protein suggests that RPE melanin promotes cell attachment and modulates
IL-6 expression. Further study is needed to explore the possibility of RPE pigmentation in
modulating a down regulatory effect in these cells, potentially suppressing immune-regulated
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mechanisms of cell detachment and retinal tissue damage. In addition to elucidating signaling
mechanisms involved in pigmented-mediated cell attachment processes, we are currently
conducting similar studies with aged human-donor melanin to further assess the effects of
chemical changes to melanin, namely oxidative degradation, on RPE cell behavior. The
presented work illustrates a novel role for RPE melanin in modulating cellular activities, such as
cell attachment to ECM substrate and regulating immune response.

CHAPTER 5

IN VITRO ASSESSMENT OF LIPOSOMAL DELIVERY OF L-DOPA FOR AMD
TREATMENT AND EFFECTS OF L-DOPA OXIDATION PRODUCTS

Introduction

Age-related macular degeneration (AMD) is the leading cause of blindness in developed
countries. This condition is the result of damage to the macular region of the retina, which is
responsible for sharp central vision. AMD can be classified as either atrophic (dry AMD) or
exudative/neovascular (wet AMD). Dry AMD is characterized by presence of drusen deposits,
composed of undigested cellular metabolites, including lipofuscin, which has been shown to
increase with age. Wet AMD is characterized by the growth of abnormal blood vessels from the
choroid underneath the macula that leak blood and fluid into the retinal space, permanently
damaging the retinal surface in the process. Currently, anti-VEGF treatments are available for
attenuating neovascularization in wet AMD patients; however, there is no approved treatment for
dry AMD.
A relationship of interest is the potential link between AMD and ocular pigmentation.
Several groups have reported that lipofuscin formation is reduced in the presence of melanin,
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thereby reducing the chances of AMD development and progression (Sundelin et al, 2001;
Weiter et al, 1986; Young 1988). Also, it has been reported that the risk of AMD is 40 times
higher in Caucasians compared to darker skinned ethnicities (Pauleikoff & Holz, 1996). While
melanin exhibits anti-oxidant properties in retinal pigment epithelial (RPE) cells, degradation of
the pigment can result in formation of melanolipofuscin, a lipofuscin-melanin complex that may
contribute to the pathogenesis of AMD (Z. Wang et al, 2006a).
L-DOPA has been identified as a ligand for the OA1 protein, also refered to as GPR143
(Lopez et al, 2008). Mutations to the OA1 protein result in ocular albinism, a condition
characterized by a lack of ocular pigmentation. GPR143 is exclusively expressed in pigmented
cells and is involved in the growth and maturation of melanosomes (Yan et al, 2012). A
retrospective data mining study found that there was an eight-year delay in the onset of AMD in
patients who were taking L-DOPA for movement disorders, such as Parkinson’s disease, versus
AMD patients who were not taking the supplement (Brilliant et al, 2016). It is proposed that
benefits of an L-DOPA supplement is the result of activating GPR143 signaling, causing RPE
cells to secrete the neurotropic factor pigment epithelium-derived factor (PEDF), which
concurrently decreases VEGF expression (Falk et al, 2012). It has been proposed that oral or
intravenous administration of L-DOPA at a dose of approximately 200-500 mg per day can be
used to target OA1 receptors for AMD treatment (McKay & Martens, 2016).
L-DOPA is an amino acid precursor of the neurotransmitter dopamine, used in the
treatment of Parkinson's disease by targeting the nigrostriatal pathway, and is also an
intermediate of melanin biosynthesis. Parkinson’s disease (PD) is a long-term neurodegenerative
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disease affecting the motor system due to cell death in the brain’s basal ganglia and
dopaminergic neurons in the nigrostriatal pathway. It has been reported that patients with wet
AMD are at 2.57 times higher risk of Parkinson’s disease (Chung et al, 2014). This increased
probability was attributed to the effect of indirect vascular risk factors, complement activation,
and inflammatory response due to microglia activation resulting in neurodegeneration in the
retina and brain.
It is known that L-DOPA has low bioavailability due to facile metabolization of the
supplement prior to reaching and crossing the blood-brain barrier (Hardie et al, 1986). Under
basic conditions, L-DOPA rapidly oxidizes to dopaquinone, followed by spontaneous conversion
of dopaquinone to red dopachrome, resulting in oxidation of 50.9% of the drug. After 24 hrs at
neutral pH, 47% of the drug was oxidized (Y.Z. Zhou et al, 2012). These observations bring into
question the availability of L-DOPA to the RPE with oral administration of the drug. Not only
would the supplement be subject to metabolization, but it would also have to efficiently cross the
blood-retina barrier, analogous to crossing the blood-brain barrier in Parkinson’s disease
treatment.
In this study, L-DOPA oxidation products are characterized and the in vitro effects of
these products in RPE cells are studied. We also propose and explore a liposomal delivery
system for L-DOPA, in which the supplement is stabilized and the toxicity of oxidation products
is reduced. Optimization of an efficient drug delivery system for L-DOPA to the retinal space
can be used in the development of readily accessible treatment for dry AMD.
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Results

L-DOPA Oxidation Products

At pH 7.4, L-DOPA undergoes oxidation. Figure 5.1a shows the UV-Vis spectra of LDOPA and oxidized L-DOPA after 3 days in PBS at pH 7.4. The solution was stored with
minimal exposure to light. Under these conditions, L-DOPA does not undergo complete
oxidation, as evidenced by the presence of its characteristic absorbance maxima. Figure 5.1b
shows the absorbance of L-DOPA in pH 7.4 solution after 35 days. After this time period, there
is substantial oxidation; however, the starting material has not been fully oxidized. In order to
accelerate the complete oxidation of L-DOPA starting material, the substance was reacted at pH
10. Figure 5.2a shows the LC/MS base peak chromatograms of L-DOPA oxidation at pH 10
over a 4.5 hr time period. After 24 hrs, L-DOPA was completely consumed in the reaction and
oxidation products were separated using LC/MS. Figure 5.2b shows the base-peak
chromatogram for the separation of L-DOPA oxidation products following this time period.
Table 5.1 lists the retention time, m/z, and fragmentation data for L-DOPA oxidation products.
These hydrophobic oxidation products were separated and collected for in vitro experiments with
ARPE-19 cells.
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(a)

(b)

Figure 5.1 Absorbance spectra of L-DOPA oxidation products at pH 7.4 a) UV-Vis spectra of LDOPA and L-DOPA oxidation at pH 7.4 after 3 days in solution. b) UV-Vis spectrum of LDOPA oxidation at pH 7.4 after 35 days in solution.
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(a)

L-DOPA

(b)

Figure 5.2 LC/MS of pH 10 L-DOPA oxidation products a) Base-peak LC/MS chromatogram of
L-DOPA oxidation at pH 10. Reaction progresses from 3.5 min to 4.5 hrs. b) Base-peak
chromatogram of L-DOPA oxidation products after full consumption of L-DOPA starting
material.
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Table 5.1 L-DOPA oxidation products and fragment ion data.

Retention time

m/z

MS/MS fragments

23.9 min

383

365 355 337 309 265

25.4 min

365

347 319 301

26.8 min

462

444 418 400 372

28.6 min

490

472 446 402 384

30.9 min

341

313 327
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Effect of L-DOPA Oxidation Products on RPE Cell Viability and Lysosome Membrane
Permeability and Function

MTT assay was used to assess ARPE-19 cell viability after UV-C exposure. UV-C was
used as a means of photic stress to solicit DNA damage in these cells and to serve as a proxy for
aging in our model system. Cells were briefly exposed to UV-C and were then incubated with
10 µM L-DOPA or L-DOPA oxidation products. The concentration of oxidation product starting
material was matched to the unreacted L-DOPA supplement concentration. Cells were incubated
with supplement for 24 hrs prior to performing the MTT assay. Figure 5.3 shows the RPE cell
viability after performing the UV-C rescue assay with L-DOPA and L-DOPA oxidation product
supplement. Cell viability is shown relative to dark-treated control cells, which received neither
supplement. In dark-treated RPE cells, L-DOPA feeding resulted in a 66% increase compared to
control cells (p < 0.0001). With UV-C exposure, L-DOPA-rescued cells were significantly more
viable versus dark-treated control cells (p ≤ 0.05). Dark-treated RPE cells supplemented with LDOPA oxidation products showed a 16% decrease in viability versus dark-treated control cells.
There was no significant difference in viability when cells were fed L-DOPA oxidation products
versus control cells, with UV-C or dark treatment. In unpigmented RPE cells, L-DOPA appears
to have a beneficial effect on cell viability and significantly rescues these cells from high-energy
photic stress, whereas L-DOPA oxidation products do not appear to contribute to increased cell
viability or rescue.
Lysosome membrane permeability was tested by staining cells with acridine orange
(AO). In acidic organelles, such as lysosomes, AO will fluoresce red. In a more basic
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Figure 5.3 Effect of L-DOPA oxidation products on ARPE-19 cell viability. *p ≤ 0.05, **p <
0.01, ***p < 0.001, ****p < 0.0001. P-values are compared to control dark cells unless
otherwise indicated.
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environment, such as the cytoplasm, the dye will fluoresce green. Flow cytometry was used to
monitor the change in red and green fluorescence in L-DOPA and L-DOPA oxidation product
fed cells. Neutral Red assay was used to assess lysosome function. Uptake and retention of
Neutral Red dye is dependent on active transport by lysosomes.
Cells were incubated for 24 hrs with supplement; however, cells were not exposed to
UV-C for these experiments. Cells were then briefly incubated with AO or Neutral Red as
described in Material and Methods. AO-stained cells were prepared for flow cytometery
analysis after staining. Figure 5.4a shows an example of flow cytometry data for RPE cells fed
with L-DOPA oxidation products. With increasing lysosome membrane permeability, the
sample population will shift from Q2 to Q3 as a result of decreased red fluorescence. Decreased
green fluorescence may indicate increased permeability of the cell membrane. Figure 5.4b
shows the relative populations of cells with permeated lysosomal membranes (% LMP).
Populations are described relative to control cells. A significant increase in the LMP cell
population was seen with L-DOPA oxidation product feeding versus both control and L-DOPA
fed cells (p < 0.001, p < 0.01). A 94% increase in LMP was observed in oxidation product fed
cells versus control cells. L-DOPA fed RPE cells had a 16% increase in LMP population versus
control cells, which was not statistically significant. LMP results were confirmed using the
Neutral Red assay (Figure 5.4c). A significant decrease in Neutral Red dye uptake and retention
was observed in oxidation product fed cells versus both control and L-DOPA-fed cells (p <
0.0001 and p < 0.001). Feeding L-DOPA oxidation products to RPE cells increased lysosomal
membrane permeability and compromised lysosome function. These effects may be due to the
hydrophobicity of these oxidation products.
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(a)

(b)

(c)

Figure 5.4 Effect of L-DOPA oxidation products on ARPE-19 cell lysosome membrane
permeability. a) Example of flow cytometry data showing movement of cell population into Q3
with increased lysosome membrane permeability. b) Percent of RPE cells with ruptured
lysosomal membranes. c) Relative absorbance of Neutral Red dye. Lysosome function
corresponds to increased uptake of dye. **p < 0.01, ***p < 0.001, ****p < 0.0001.
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Efficiency of Liposomal Delivery to RPE Cells using a Fluorescein Model System

In order to stabilize the delivery of L-DOPA to RPE cells in vitro, L-DOPA was
encapsulated in liposomes. To test the efficiency of liposomal uptake by ARPE-19 cells,
fluorescein-encapsulated liposomes were fed to cells and intracellular fluorescence was detected
using flow cytometry. A matched concentration of fluorescein was fed to cells directly in media
for comparison. As an additional control, cells were fed liposomes encapsulated with buffer
only. Figure 5.5a shows a sample histogram of intracellular fluorescence for RPE cells. Shifts in
fluorescence relative to control cells were used to determine fluorescent populations. Figure
5.5b shows the fluorescent population of RPE cells fed fluorescein directly in media or
liposome-encapsulated fluorescein; 99 ± 1% percent of RPE cells fed dye directly in media were
fluorescent, and 90 ± 2% of cells fed liposome-encapsulated dye were fluorescent. The relative
intracellular fluorescence intensity of these RPE cells is shown in Figure 5.5c. Intensity is
shown relative to control cells. Intracellular fluorescence of RPE cells fed fluorescein directly in
media is significantly greater than cells fed liposome-encapsulated fluorescein (p < 0.0001). The
difference in fluorescence intensity may be due to stabilization of the dye in liposomes during
delivery to cells. This effect may also be due to self-quenching of the dye in the liposome
vesicles.
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(a)

(c)

(b)

Figure 5.5 Characterization of liposome uptake efficiency by ARPE-19 cells using fluorescein
probe. a) Example flow cytometery histogram of intracellular fluorescence intensity in RPE cells
b) Percent fluorescent RPE cell population. c) Relative intracellular fluorescence intensity in
RPE cells. ****p < 0.0001.
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Effect of L-DOPA Encapsulated Liposomal Delivery to RPE Cells after UV-C Exposure

The stabilization of L-DOPA delivery to UV-C-stressed ARPE-19 cells was then
evaluated using MTT assay and Neutral Red assay. Cells were briefly exposed to UV-C as
previously described and were then supplemented with L-DOPA directly in the media or LDOPA-encapsulated liposomes. Changes in cell viability and lysosome function were monitored
for 1, 3 and 5 days after irradiation and supplement feeding. Buffer-encapsulated liposomes
were used as an additional control in these experiments. Results are shown in Figure 5.6. In
dark-treated cells, L-DOPA supplemented either directly in media or in liposomes significantly
increased cell viability (p < 0.0001) versus control cells over the course of 1, 3 and 5 days. With
UV-C irradiation, RPE cell viability decreases over a 5-day period. A significant increase in cell
viability was observed in cells rescued with L-DOPA directly in media or in liposomes versus
control cells (p < 0.0001) on Days 1, 3, and 5. UV-C-exposed cells rescued with L-DOPAencapsulated liposomes showed a trend of increased viability versus cells fed L-DOPA directly
in media, with an average 21 ± 1% over the 5-day period. Figure 5.6b shows the Neutral Red
assay results. Lysosome uptake of Neutral Red dye was significantly increased in L-DOPA
liposome-fed cells after UV-C exposure over the 5-day period. On Day 1, with UV-C, L-DOPA
liposome-fed cells showed a significant increase in dye uptake versus control cells (p ≤ 0.01).
On Day 3 and Day 5, UV-C exposed cells that were fed L-DOPA liposomes showed a significant
increase in Neutral Red uptake versus both irradiated control and L-DOPA-fed cells (p < 0.001
and p ≤ 0.05). These observations suggested stabilized delivery of L-DOPA to RPE cells in an
oxidative cellular environment compared to directly supplementing L-DOPA into media.
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(a)

(b)

Figure 5.6 ARPE-19 cell viability and lysosome function using UV-C rescue assay. Cells were
rescued with L-DOPA directly in solution or with L-DOPA-encapsulated liposomes. a) Cell
viability, b) lysosome function.
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Discussion

L-DOPA is an intermediate of melanogenesis in pigmented cells and has been implicated
as a necessary factor in the development of the retina. In mice with pigmented RPE, L-DOPA is
at its highest concentration in the retina during fetal development and drops off in the postnatal
stage. In the retina of fetal albino mice, there are low or undetectable levels of L-DOPA, with
levels remaining low after birth (Roffler-Tarlov et al, 2013). This decline in accumulated LDOPA in the pigmented retina occurs after differentiation of retinal neurons, suggesting a key
role for L-DOPA during retinal development. Evidence suggests that L-DOPA is a regulator of
mitosis, with findings that mitosis is accelerated in the neurosensory retina of albino mice
coupled to abnormal orientation of mitotic spindles during division (Hans et al, 2006; Ilia &
Jeffery, 1999; Kralj-Tibber et al, 2006). Interestingly, these abnormalities were corrected by
administering subcutaneous injections of L-DOPA to albino mice.
Ocular albinism has been associated with mutations to the OA1 protein, which is only
expressed in pigmented cells (Bassi et al, 1995; Schiaffino et al, 1995). It has been reported that
L-DOPA is a ligand for OA1, stimulating secretion of the neurotropic factor pigment epitheliumderived factor (PEDF). Blocking the activity of tyrosinase, the melanogenesis enzyme that
produces L-DOPA, can inhibit PEDF secretion (Lopez et al, 2008). It has also been reported
that OA1 reciprocally regulates PEDF and VEGF-A secretion in response to L-DOPA in human
RPE cells, suggesting the importance of this protein-ligand complex in mediating angiogenesis
in the retina (Falk et al, 2012). This implicates L-DOPA as having a role in the pathogenesis of
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wet AMD. Deficiencies in the production of the melanin intermediate can thus have mechanistic
consequences, disrupting function of OA1 in the retina. In the pigmented cell, OA1 is an
endosomal protein localized to lysosomes and melanosomes. Disruptions to OA1 function can
result in formation of disorganized macromelanosomes in addition to abnormal trafficking and
displacement of melanosomes from the cytoplasm to the periphery of the cell (Palminsano et al,
2008). It has even been proposed that OA1 regulates melanosome maturation by limiting the
transport of premelanosome proteins to lysosomes for degradation (Burgoyne et al, 2013). The
given evidence suggests that OA1 is necessary for progressing late stages of melanogenesis and
requires the early-stage intermediate of this process, L-DOPA, to mechanistically maintain
retinal health. This also poses the question of continued melanogenesis in the RPE into later life
stages, as L-DOPA production would heavily rely on tyrosinase activity. The presented work
utilizes an unpigmented human RPE cell line to assess benefits of L-DOPA in the absence of
melanin. Our findings suggest that L-DOPA supplements are able to rescue unpigmented RPE
cells from oxidative stress conditions. The absence of pigmentation in these cells accounts for
the activity of L-DOPA in a cell system lacking endogenous antioxidants and protective factors,
namely melanin. Oxidation products of L-DOPA did not induce significant changes to RPE cell
viability with or without photic stress.
Oral administration of L-DOPA is a common treatment for Parkinson’s disease, where
the molecule behaves as a prodrug for dopamine, which is unable to cross the blood-brain
barrier. L-DOPA has relatively poor oral bioavailability of 30%, with an estimated less than 1%
of the unmetabolized drug reaching the brain in the absence of decarboxylase inhibitors
(Standaert & Young, 1996). Even with decarboxylase inhibitors, side effects of oral L-DOPA
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supplements are evident in the fluctuations of plasma concentrations coupled to motor
fluctuations (Hardie et al; 1984; Nutt & Woodward, 1986; Quinn et al, 1984). The neurotoxicity
of L-DOPA has not been firmly established in the scope of long-term use (Muller et al, 2004);
however, it is speculated that the dopamine oxidation product, aminochrome, can participate in
neurotoxic reactions in the absence of DT-diaphorase and glutathione transferase M2-2 (Herrera
et al, 2017). Oral L-DOPA supplements have been proposed as a treatment for AMD (Snyder
2017); however, similar side effects and poor bioavailability would be anticipated with regard to
systemic metabolization of L-DOPA, in addition to difficulties crossing the blood-retina barrier.
It is also possible that oxidation of L-DOPA in the RPE can disrupt intended benefits via OA1
stimulation, as it has been found that dopamine competes with L-DOPA for OA1 binding,
suggesting this decarboxylation product could behave as an antagonist ligand (Lopez et al,
2008). Additionally, it has been found that L-DOPA oxidation disrupts the cell cycle of RPE
cells in vitro (Akeo et al, 1994).
Our results suggest that L-DOPA oxidation products may facilitate RPE cell damage by
inducing lysosome membrane permeability (LMP) and compromising lysosome function. It is
known that lysosomal damage can initiate cell death pathways through several mechanisms such
as release of cathepsins and caspase activation (Boya & Groemer, 2008). Additionally,
compromise to the lysosomal membrane can result in the leakage of proteases and undigested
materials into the cytosolic fluid. With regard to the RPE, the release of these components into
the cell could possibly contribute to the formation of drusen deposits. Drusen deposits in the
macula are considered a hallmark of AMD progression, and histochemical and proteomic
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analysis of these deposits has revealed a host of undigested proteins in the composition of these
extracellular deposits (Hageman & Mullins, 1999; Mullins et al, 2000; Rudolf et al, 2008).
Interestingly, the incorporation of L-DOPA into synthetic proteins has been shown to
induce apoptosis in human monocytes via LMP initiation (Dunlop et al, 2011). We found that
exposure to L-DOPA oxidation products significantly increased the population of RPE cells that
exhibited LMP. We confirmed these results by testing lysosomal uptake and retention of Neutral
Red dye in oxidation product fed cells. The hydrophobicity or possible detergent-like qualities
of these oxidation products may explain increased membrane permeability in our in vitro system.
The implication of these findings suggests toxicity of long-term L-DOPA oral supplements for
AMD treatment. The possibility of systemic oxidation of large doses of L-DOPA necessitates
the need for controlled or sustained delivery and release of the drug to the RPE for a more safe
and effective outcome.
In this study we probed the effect of L-DOPA supplements on unpigmented RPE cells in
vitro. We found that L-DOPA supplements rescued viability in photo-stressed RPE cells, while
L-DOPA oxidation products did not show any effect. While L-DOPA oxidation products did not
significantly affect RPE cell viability, these compounds did facilitate lysosome membrane
permeabilization, suggesting damaging effects of these molecules. This work also tested
stabilized delivery of L-DOPA to RPE cells in vitro using liposomes. Under oxidative stress
conditions, liposomal delivery to cells stabilized L-DOPA supplements as evidenced by
increased viability and active transport via lysosomes, versus L-DOPA added directly in media.
This work supports the proposed benefits of L-DOPA in treating AMD and addresses potential
side effects of unregulated delivery of this supplement to RPE cells.

CHAPTER 6

THE ANTHOCYANINS, OENIN AND CALLISTEPHIN, PROTECT RETINAL PIGMENT
EPITHELIAL CELLS AGAINST OXIDATIVE STRESS

Introduction

Anthocyanins are naturally occurring pigment compounds found in red, blue, and purple
fruits and vegetables. As polyphenols, anthocyanins are considered to be potent dietary
antioxidants and have been shown to have substantial antioxidant capacity (G. Cao et al, 1997;
Faria et al, 2005; Moyer et al, 2002; Vinson et al, 1995; H. Wang et al, 1997; Youdim et al,
2000; Zafra-Stone et al, 2007). It has been reported that intact anthocyanins can be detected in
human blood plasma and urine after consumption (G. Cao & Prior, 1999; X. Wu et al, 2002). In
vivo studies have even suggested that consumption of foods rich in anthocyanins increases
plasma and serum antioxidant capacity due to high polyphenol concentration in these foods (G.
Cao et al, 1998; Vinson et al, 2005).
It has been proposed that anthocyanins may have therapeutic potential in preventing or
attenuating chronic disease associated with oxidative stress and inflammation. Epidemiological
studies have demonstrated that anthocyanins modulate anti-inflammatory activity by down
regulating proinflammatory cytokine expression, suppressing secretion of these cytokines,
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(Björk et al, 2016; Min et al, 2015; Olejnik et al, 2016; T. Wu et al, 2016), and by scavenging
intracellular reactive oxygen species (ROS); (Matias et al, 2016; Park et al, 2010). It has even
been suggested that the anthocyanin cyanidin-3-O-glucoside and its metabolites can attenuate
photic-stress-induced oxidative damage to the retina by suppressing activation of
proinflammatory genes in vivo (Y. Wang et al, 2016). In addition, it has also been shown that
anthocyanins have an inhibitory effect on cancer cell proliferation in vitro and are capable of
inducing apoptosis in these cells (Fernandes et al, 2010; Katsube et al, 2003).
Interestingly, it has been reported that anthocyanins can pass the blood-retina barrier and
accumulate in the retina, detectable hours after ingestion (Matsumoto et al, 2006). Given this
information, a number of studies have investigated the ability of anthocyanins to inhibit
oxidative stress in retinal pigment epithelial (RPE) cells (R. Chen et al, 2014; Hanneken et al,
2006; Jang et al, 2005; Liu et al, 2012; Y. Wang et al, 2014). However, in some cases these
compounds were supplemented to cells at doses that exceed physiologically relevant
concentrations. In cases where photic stress was used on RPE cells, it is possible that the
observed benefits of anthocyanins were predominantly the result of light filtering rather than
antioxidant behavior.
This study focuses on the protective effects of low-dose anthocyanin supplements against
blue-light-mediated mitochondrial damage to RPE cells in vitro. Blue light exposure to RPE
cells has been shown to elicit mitochondrial DNA damage and dysfunction in addition to
increased generation of ROS (E. Chen, 1993; Godley et al, 2005; King et al, 2004; Seko et al,
2001;). Mitochondrial damage has been implicated in retinal degeneration and in the
pathogenesis of age-related macular degeneration (AMD); (He et al, 2010; Nordgaard et al,
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2008; Yakes & Van Houten, 1997). Lesions in mitochondrial DNA have been shown to
contribute to oxidative stress and induce secretion of proinflammatory cytokines in RPE cells
(Dib et al, 2015; Liang & Godley, 2003).
Anthocyanins may provide a simple and accessible solution to protecting RPE cell
mitochondria from blue-light mediated-damage and attenuating RPE cell damage with age.
Anthocyanins pelargonidin-3-O-glucoside (callistephin); (Figure 6.1a) and malvidin-3-Oglucoside (oenin); (Figure 6.1b) were used in this study to examine the potential benefits of these
dietary antioxidants in protecting photo-stressed ARPE-19 cells. Oxidation products of
callistephin and oenin were analyzed using liquid chromatography mass spectrometry (LC/MS)
to probe structural changes to these anthocyanins.

Results

Effect of Anthocyanin Supplement on ARPE-19 Mitochondria Activity
The MTT assay was used to examine the effect of anthocyanin supplement on the
mitochondrial redox activity in ARPE-19 cells. Either callistephin or oenin was fed to cells at 0
µg/mL, 0.1 µg/mL, or 1 µg/mL concentrations and cells were subjected to 30 min of blue light
irradiation or dark treatment. Mitochondrial function is measured by the ability of viable cells to
reduce MTT to formazan and the results are shown in Figures 6.2a and 6.2b. Figure 6.2a shows
the effect of callistephin supplements on blue-light-irradiated ARPE-19 cells. A decrease in
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(a)

(b)

Figure 6.1 Structures of a) pelargonidin-3-O-glucoside (callistephin) and b) malvidin-3-Oglucoside (oenin)
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(a)

(b)

Figure 6.2 Mitochondrial activity of anthocyanin-supplemented ARPE-19 cells assessed using
MTT assay. a) Callistephin-supplemented cells. *p < 0.05, s p ≤ 0.05. b) Oenin-supplemented
cells. ** p ≤ 0.002, * p < 0.05, s p ≤ 0.01. P-values are compared to dark-treated 0 µg/mL. s Pvalues are compared to blue-light-irradiated 0 µg/mL.
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mitochondrial redox activity was observed between dark-treated and blue-light-irradiated cells,
with neither group receiving anthocyanin supplement (p < 0.05).
A significant increase in formazan production was observed in dark treated cells that
received 1 µg/mL dose of callistephin compared to unsupplemented dark control cells (p < 0.05).
Blue-light-irradiated cells supplemented with 1 µg/mL of callistephin showed a significant
increase in redox activity compared to blue-light-irradiated cells that received no anthocyanin (p
≤ 0.01). Cells that received 0.1 µg/mL of callistephin showed an increase in formazan
production compared to dark-treated and blue-light-irradiated control cells; however, these
results were not statistically significant.
The results for the effect of oenin supplements on APRE-19 cell mitochondrial activity
are shown in Figure 6.2b. At both 0.1 µg/mL and 1 µg/mL doses, oenin supplementation to
dark-treated ARPE-19 cells resulted in a significant increase in formazan production (p ≤ 0.002)
versus unsupplemented dark control cells. Blue-light-irradiated cells fed 0.1 µg/mL or 1 µg/mL
of oenin also showed a significant increase in mitochondrial activity compared to dark control
cells (p < 0.05, p ≤ 0.002). Irradiated groups supplemented with 0.1 µg/mL or 1 µg/mL of oenin
also showed a significant increase in formazan production compared to unsupplemented
irradiated cells (p ≤ 0.01). Based on results from the MTT assay, oenin supplementation to
ARPE-19 cells appears to have an overall greater protective effect on ARPE-19 cells compared
to callistephin.
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Effect of Anthocyanin Supplement on Intracellular ROS Formation in ARPE-19 Cells

The formation of intracellular reactive oxygen species in ARPE-19 cells was measured
using 2’,7’-dichlorodihydrofluorescein diacetate (H2DCFDA). H2DCFDA is capable of
permeating the cell membrane. Inside the cell, esterases cleave acetate groups from the dye and
intracellular ROS oxidize the dye. The fluorescent signal from oxidized DCF is measured and
used as an indicator for the presence of intracellular ROS. For this study, solutions containing
H2DCFDA were subjected to 30 min of blue light irradiation to ensure observed fluorescence
was not the result of photo-oxidation of the dye (Figure 2.2). Flow cytometry was used to detect
intracellular fluorescence in ARPE-19 cells supplemented with 0 µg/mL, 0.1 µg/mL, or 1 µg/mL
of anthocyanin. Cells were incubated with 1 µM H2DCFDA in PBS for 20 min prior to
anthocyanin supplementation. Figure 6.3 shows the observed shift in fluorescence signal of
dark-treated cells versus blue-light-irradiated cells dyed with H2DCFDA.
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Figure 6.3 Flow cytometery histogram of intracellular ROS production in blue-light-irradiated
ARPE-19 cells. Increased DCF fluorescence was observed in the blue-light-irradiated cell
population compared to the dark-treated group. Dark-treated and irradiated populations that did
not receive dye show an overlap in fluorescence signal.

Figures 6.4 shows the effect of anthocyanin supplement on intracellular ROS formation
in ARPE-19 cells. The effect of callistephin on intracellular ROS production is shown in Figure
6.4a. A 29% increase in DCF fluorescence was observed in cells subjected to 30 min of blue
light irradiation compared to dark-treated cells (p < 0.0001). A significant decrease in
intracellular ROS was observed in dark-treated cells receiving either 0.1 µg/mL or 1 µg/mL of
callistephin versus unsupplemented control cells (p < 0.01, p< 0.0001). Dark-treated cells fed
0.1 µg/mL of callistephin showed a 10% decrease in fluorescence while cells fed 1 µg/mL
showed a 26% decrease. While callistephin-supplemented cells did not show a significant
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decrease in intracellular ROS after blue light irradiation compared to dark unsupplemented
control cells, a significant decrease was observed compared to irradiated cells that did not
receive anthocyanin (p ≤ 0.003). In these cases, irradiated cells supplemented with 0.1 µg/mL of
callistephin showed a 14% decrease in fluorescence compared to irradiated control cells, and a
25% decrease was observed for cells fed 1 µg/mL of callistephin.
The effect of oenin supplement on intracellular ROS production in ARPE-19 cells is shown in
Figure 6.4b. Dark-treated cells supplemented with 0.1 µg/mL of oenin showed a 23% decrease
in DCF fluorescence compared to unsupplemented dark control cells (p < 0.0001), whereas cells
supplemented with 1 µg/mL of oenin showed a 44% decrease (p < 0.0001). A 15% decrease in
fluorescence was observed in blue-light-irradiated cells fed 0.1 µg/mL of oenin (p < 0.001) and a
34% decrease was seen in cells fed 1 µg/mL of oenin, versus unsupplemented dark control cells.
Blue-light-irradiated cells supplemented with either dose of oenin showed a significant decrease
in DCF fluorescence compared to irradiated cells that did not receive anthocyanin (p < 0.0001).
At both tested doses, oenin appears to be more effective at decreasing intracellular ROS
production in ARPE-19 cells compared to callistephin.

Antioxidant Activity of Anthocyanins in Solution
The antioxidant activity of callistephin and oenin were tested using H2DCFDA in
solution. Solutions containing 1 µg/mL of either anthocyanin were added to 200 µM H2DCFDA
in PBS. H2DCFDA was oxidized with the addition of H2O2 and increased H2DCFDA
fluorescence was used as an indicator for oxidation of the dye.
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(a)

(b)

Figure 6.4 Intracellular ROS production in anthocyanin-supplemented ARPE-19 cells a)
Callistephin-supplemented cells. * p < 0.01, ** p < 0.0001, s p ≤ 0.003). b) Oeninsupplemented cells. * p < 0.001, ** p < 0.0001, s p < 0.0001. P-values are compared to darktreated 0 µg/mL. s P-values are compared to blue-light-irradiated 0 µg/mL.
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The results for this assay are shown in Figure 6.5. A 22% increase in H2DCFDA fluorescence
was observed after the addition of peroxide to solution (p < 0.001). In H2DCFDA solutions
supplemented with callistephin, a 2% decrease in fluorescence was observed (p < 0.05)
compared to H2DCFDA solution without anthocyanin. The addition of peroxide to the
callistephin-containing solution resulted in a 5% decrease in H2DCFDA fluorescence compared
to the peroxide treated H2DCFDA control solution (p < 0.001).
Oenin supplementation resulted in a 17% decrease in DCFDA fluorescence compared to
the H2DCFDA-only control (p < 0.001). The addition of peroxide to the oenin-containing
solution resulted in a 2% decrease in fluorescence versus the H2DCFDA-only control (p < 0.05)
and a 24% decrease in fluorescence compared to the peroxide-treated H2DCFDA solution that
did not contain anthocyanin (p < 0.0001). Both callistephin and oenin decreased H2DCFDA
oxidation in solution with a larger decrease observed in solutions containing oenin.

Anthocyanin Oxidation Products

Anthocyanin oxidation products generated by the addition of H2O2 to anthocyanincontaining solutions were analyzed using LC/MS. Figure 6.6a shows the base-peak
chromatogram for oenin, and the formation of oenin oxidation products with the addition of
peroxide is shown in Figure 6.6b. Figure 6.6c shows the base-peak chromatogram for
callistephin, and the formation of callistephin oxidation products with the addition of peroxide is
shown in Figure 6.6d. As seen in Figures 6.6b and 6.6d, the ratio of anthocyanin oxidation
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Figure 6.5 H2DCFDA fluorescence to examine antioxidant activity of callistephin and oenin.
* p < 0.05; ** p < 0.001; s p < 0.001. P-values are compared to – H2O2 H2DCFDA. sP-values
are compared to + H2O2 H2DCFDA.
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products to starting material is small. Additionally, the oxidation of callistephin with peroxide
results in two chemically distinct products, whereas oenin oxidation yields one product.
Table 6.1 lists oenin and callistephin oxidation product m/z values and fragment ion
values. Figure 6.7 shows the mass spectrum for oenin. Oenin oxidation with peroxide yields a
species with m/z 544, a 51 amu increase to oenin (m/z 493). Figure 6.8 shows the mass
spectrum for m/z 544 oenin oxidation product. Fragmentation of the oxidation product results in
loss of glucose (M – 162) as evidenced by the ion m/z 382. MS/MS of m/z 544 also yields a m/z
364 ion, which is most likely a loss of water (-18 amu) from 382. Smaller fragments observed
are m/z 199 and 181. These may be the result of cleaving the pyrilium ring or fragmentation of
the oxidized anthocyanin in the open-ring chalcone conformation. Steric repulsion between
methoxy substituents on the b-ring and glucose result in facile removal of the sugar moiety.
Proposed structures for the oenin oxidation product are shown in Figure 6.9.
Callistephin oxidation products listed in Table 6.1 include species with m/z 498 and 484.
Figure 6.10 shows the mass spectrum for callistephin. The oxidation product m/z 498 is a
difference of + 65 amu to callistephin (m/z 433). Figure 6.11 shows the mass spectrum for m/z
498 oenin oxidation product. MS/MS of 498 results in ions with m/z 481, 351, and 344. The
481 fragment is a loss of 17 amu from 498, which may correspond to elimination of water.
Fragments 351 and 344 may be the result of fragmentation of 498 species in the chalcone
conformation or pyrilium ring cleavage. Figure 6.12 shows the mass spectrum for m/z 484 oenin
oxidation product. The callistephin oxidation product with m/z 484 is an addition of 51 amu to
callistephin. MS/MS of this oxidation product yields ions with m/z 322, 304, and 167. Fragment
ion m/z 322 is a loss of glucose (M – 162) from the parent ion.
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Figure 6.6 LC/MS of oenin and callistephin oxidation products. Figure shows the base-peak
chromatograms for a) oenin starting material, b) appearance of oenin oxidation products after
treatment, c) callistephin starting material, d) appearance of callistephin oxidation products after
treatment.
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Table 6.1 Oenin and callistephin oxidation products and fragment ion data.

Oenin
Oxidation products

m/z
493
544

MS/MS fragment ions
331
382
364
199
155

MS3 fragment ions
199
155

Retention time
22 mins
24 mins

Callistephin
Oxidation products

433
498

271
481
351
344
322
304
167

-

23 mins
24 mins

-

25 mins

484
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Figure 6.7 Oenin starting material MS and MS/MS spectra.
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Figure 6.8 Oenin oxidation product m/z 544 MS and fragmentation spectra.
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Figure 6.9 Proposed structure for oenin oxidation product m/z 544 and fragmentation ions.
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The observed species with m/z 304 is a loss of 18 amu from 322, corresponding to loss of water.
The smaller fragment ion with m/z 167 may be the result of ring cleavage or fragmentation of the
open-ring chalcone conformation of the oxidized anthocyanin. Proposed structures for
callistephin oxidation products are shown in Figure 6.13.

Discussion

Anthocyanins have been well established as potent antioxidants (G. Cao et al, 1997; Faria
et al, 2005; Moyer et al, 2002; Vinson et al, 1995; ; H. Wang et al, 1997; Youdim et al, 2000;
Zafra-Stone et al, 2007) and have been shown to have health benefits in disease prevention
(Björk et al, 2016; Min et al, 2015; Olejnik et al, 2016; T. Wu et al, 2016). Regarding the retina,
these compounds have also been shown to behave as a neuroprotectant by increasing rhodopsin
regeneration (Matsumoto et al, 2003; Tirupula et al, 2009; Tremblay et al, 2013) and have been
found to have protective effects against light-induced damage (Hanneken et al, 2006; Jang et al,
2005; Liu et al, 2012; Y. Wang et al, 2014). Of particular interest to this study is the ability of
anthocyanins to protect RPE cells from blue-light-mediated damage. Blue light exposure to the
retina can result in damage to mitochondrial DNA in RPE cells, resulting in oxidative stress and
cell death (E. Chen, 1993; Godley et al, 2005; King et al, 2004; Seko et al, 2001). Age-related
abnormalities in RPE cell mitochondria morphology and reports of mitochondrial DNA damage
in AMD patients prior to vision loss implicate the role of mitochondrial damage in age-related
ocular disease (Karunadharma et al, 2010; Terluk et al, 2015).
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Figure 6.10 Callistephin starting material MS and MS/MS spectra.

128

Figure 6.11 Callistephin oxidation product m/z 498 MS and MS/MS spectra.
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Figure 6.12 Callistephin oxidation product m/z 484 MS and MS/MS spectra.
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Blue light exposure has been shown to facilitate mitochondria-dependent cell death and
structural damage to the retina in lipofuscin-free RPE cells (King et al, 2004; Pang et al, 1998),
suggesting chromophores in the RPE other than lipofuscin are involved in blue-light-mediated
damage. Respiratory enzymes in the mitochondria such as cytochrome c oxidase are thought to
behave as chromophores involved in phototoxicity (Paulter et al, 1992; Putting et al, 1993). It
has also been demonstrated in isolated RPE mitochondria that blue light exposure results in
mitochondrial DNA damage and generation of reactive oxygen species (Godley et al, 2005).
Supplementing the endogenous antioxidant system in the RPE with anthocyanins may attenuate
blue-light-mediated oxidative stress from mitochondrial damage and prevent the onset of agerelated ocular disease.
While anthocyanins are an abundant phytochemical in fruits and vegetables, these
compounds must have sufficient bioavailability to be effective as antioxidants in tissue.
Bioavailability has been shown to decrease with increasing hydroxyl group substituents and
decreasing methoxy substituents (Yi et al, 2006). Additionally, the presence of glucose as a
sugar substituent increases the bioavailability of anthocyanins, which is thought to be the result
of glucose transport receptor activity (Milbury et al, 2002). The observation that oenin better
protects ARPE-19 cells from blue-light-mediated mitochondrial damage and more effectively
inhibits intracellular ROS generation, compared to callistephin, may in part be due to the
structural relation of these anthocyanins to bioavailabilty and cellular uptake. It is possible that
methoxy-substituted anthocyanins such as oenin are better able to penetrate the cell membrane
due to increased lipophilicity. It is also possible that the positioning of the b-ring methoxy
groups on oenin plays an electronic role in the antioxidant activity of the compound by
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stabilizing the 4’ hydroxyl group anion, facilitating hydrogen donation to free radicals.
Comparatively, callistephin has hydrogens in the b-ring 2’ and 4’ positions, which may decrease
bioavailability and lessen antioxidant activity.
Anthocyanins exist in a mixture of different structures at equilibrium in aqueous solution.
At acidic pH, the flavylium cation is the dominant species. With increasing pH, there is
competition between hydration of the flavylium cation and proton transfer reactions facilitated
by acidic hydroxyl groups (Welch et al, 2008). Hydration of the flavylium cation results in the
formation of the colorless carbinol pseudo base that undergoes ring opening to the chalcone
comformation. Proton transfer reactions from phenolic hydroxyl groups lead to the formation of
quinoidal bases that can undergo further deprotonation to form resonance-stabilized quinoid
anions (Brouillard, 1988). The chromatograms of oenin and callistephin oxidation products
show a high ratio of unoxidized anthocyanin to oxidation products. Based on these observations,
it is possible that these anthocyanins are stabilized in the flavylium cation form, as there is no
evidence of hydration (+18 amu) of starting material. In the proposed structures for oenin
oxidation products, the C2, C4, and the B2’ positions are substituted with hydroxyl groups. The
increase in pH resulting from peroxide addition would favor hydration of the flavylium cation in
the oxidized structure. Hydration at the C2 position could result in ring opening to the chalcone
pseudo base. In the chalcone conformation, fragmentation would be more facile and may
explain the smaller fragment ions produced in MS/MS of the oenin oxidation product. The
electron-deficient nucleus of the flavylium cation would make the C2 and C4 positions of the
anthocyanin highly susceptible to nucleophilic attack, and so it is possible that the C4 position is
also oxidized. Additionally, it has been shown that substitution at the C4 position in
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anthocyanins slows degradation of these compounds, further suggesting this position is
susceptible to nucleophilic attack (Borkowski et al, 2005; Garcia-Viguera & Bridle, 1999).
Addition of a hydroxyl group to the B2’ position is due to the ability of anthocyanins to scavenge
free radicals, as anthocyanins are thought to scavenge free radicals by donating hydrogen from
the b-ring 4’ hydroxy substituent. It is not mechanistically clear, however possible, that attack
by a hydroxyl radical could lead to the addition of –OH to the b-ring.
In the proposed oxidation structures for callistephin, hydroxyl group additions show a
like pattern to those proposed for oxidized oenin. Interestingly, two distinct oxidation products
are observed for this anthocyanin. Compared to oenin, callistephin has more available positions
for addition and there is less steric repulsion between glucose and b-ring substituents, compared
to oenin. MS/MS of the callistephin oxidation product with m/z 498 suggests retention of the
glucose moiety in the oxidized anthocyanin structure. This may be the result of intramolecular
hydrogen bonding of added b-ring hydroxyl groups with glucose stabilizing the structure
(Borkowski et al, 2005). Fragmentation of the callistephin oxidation product with m/z 484
suggests removal of glucose from the parent ion. Rotation of the C2-B1’ bond would result in
multiple conformations for this oxidation product where hydrogen bonding between the added bring hydroxyl group and glucose is possible. The oxidation products of these anthocyanins may
explain the observable protective effect of these compounds in dark-treated RPE cells as the
apparent structural modifications suggest antioxidant behavior in the presence of ROS.
This work supports the hypothesis that in vitro the anthocyanins callistephin and oenin
behave as antioxidants against blue-light-mediated photo-oxidation in human RPE cells. Lowdose supplements of these compounds promoted mitochondrial redox activity and decreased
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production of intracellular reactive oxygen species in treated cells. Oenin proved to be a more
effective antioxidant at tested doses in cell-based and solution assays compared to callistephin.
Differences in the antioxidant activity of these compounds may be due to bioavailability and
structure-activity relationships. Methoxy substituents on the b-ring of oenin may make this
anthocyanin more available for uptake in RPE cells while enhancing the antioxidant capacity of
this compound.

CHAPTER 7

CONCLUSIONS AND FUTURE WORK

With increasing age, the retina undergoes a number of biochemical changes that result in
compromised vision. This dissertation studied molecular mechanisms of the aging retina and
accessible therapeutics to attenuate, and perhaps prevent, tissue damage. The results of this
works suggest that endogenous factors in the RPE modulate the cellular environment,
contributing to pathologic changes to the retina over time.
The pathogenesis of retinal diseases, such as AMD, results in degeneration of the RPE.
Compromise to the RPE leads to photoreceptor dysfunction and eventually vision loss. Bruch’s
membrane serves as a substrate for RPE cell attachment, and modifications to this extracellular
matrix layer will facilitate RPE cell damage. In studying vision loss, consideration must be
given to the dependency of retinal layers in maintaining the necessary functions for signal
transduction. The RPE serves as a unifying layer between the neurosensory retina and the
Bruch’s membrane subspace. The RPE layer is a primary site for retinal damage. This work
investigated mechanisms of RPE cell dysfunction to better understand mechanisms and risk
factors for vision loss.
Over time, endogenous antioxidants in the RPE are depleted, making the tissue more
susceptible to damage mediated by oxidative stress (Hayes, 1974; Katz et al, 1982; Liles et al,
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1991). Melanin is a characteristic antioxidant of the RPE; however, it is speculated that
chemical changes to the pigment with age can alter its protective abilities. The presented work
shows that RPE melanin undergoes changes consistent with oxidative degradation with
increasing age. We also show that aged melanin loses antioxidant capacity and is capable of
behaving as a pro-oxidant. Melanin is a heterogeneous polymer and, typically, an insoluble
material. These features limit what is known about the structural and functional changes to
melanin with age. Given the challenges of working with the melanin polymer, melanin
degradation products continue to be discovered (Ito et al, 2016; Ito et al, 2013). It would be of
interest to study how these degradation products contribute to the formation of RPE components,
such as melanolipofuscin and drusen deposits. Additionally, further study into the compositional
dependency of melanin in forming specific degradation products would be a valuable tool for
assessing the risk for developing hallmark components of AMD, such as drusen.
Immune dysfunction and inflammation have been implicated in the pathogenesis of
AMD, but there are no comprehensive mechanisms to describe immune regulation in the retina
(Edwards et al, 2005; Haines et al, 2005; Klein et al, 2005). To date, the functions of RPE
melanin are not fully understood. It is known that melanin can protect the RPE by behaving as
an antioxidant and photoprotectant, but there has been no consideration to the possibility of RPE
melanin modulating cell signaling, namely in immune response and inflammation (Burke et al,
2011; Seagle et al, 2006; Seagle et al, 2005; Z. Wang et al, 2006a). We investigated a novel role
for RPE melanin in modulating immune response. We found that the presence of melanin in
RPE cells induced IL-6 expression. In this study, we also considered how age-related changes to
extracellular matrix proteins could influence immune response in the RPE and found that
glycated extracellular matrix protein mediated IL-6 expression in RPE cells. Our findings
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support the hypothesis that glycated Bruch’s membrane proteins can modulate cytokine
signaling, linking extracellular matrix protein modification to disease progression (Fields et al,
2015Howes et al, 2004; Ma et al, 2007; Tian et al, 2005). This work opens up further
investigations into the role of melanin in modulating immune response and inflammation via
known or novel pathways. It would also be of great interest to examine how age-related changes
to melanin may affect these signaling pathways in the RPE.
AMD is the leading cause of blindness in developed countries (World Health
Organization, 2017). Currently, antiangiogenesis treatments are available for wet AMD, but
there are no treatment options for dry AMD patients. L-DOPA has recently received attention as
a potential treatment option for both dry and wet AMD (Brilliant et al, 2016; McKay & Martens,
2016; Lopez et al, 2008). The drug is already approved for use in Parkinson’s disease treatment
and has been shown to increase PEDF secretion in RPE cells (Falk et al, 2012). The current
proposal for AMD patients to take an oral L-DOPA supplement presents a challenge, as LDOPA would have low availability to the retina. As is seen in Parkinson’s treatment, L-DOPA
is subject to systemic metabolization and must also cross the blood-brain barrier. Similarly, LDOPA would have to cross the blood-retina barrier to reach the RPE. Our study investigates the
effect of L-DOPA and L-DOPA oxidation products on unpigmented RPE cells. We also
evaluated the efficacy of a liposomal delivery system for the supplement. Our findings suggest
that L-DOPA oxidation products can facilitate damage to RPE cells, and liposomal delivery of
L-DOPA can increase RPE cell viability and prevent oxidation of the drug. Our liposomal
delivery system can be further developed for in vivo testing to better characterize the release and
optimized dose rate of L-DOPA to the retinal space.
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Plant-derived polyphenols, such as anthocyanins, have been proposed to have therapeutic
potential in treating oxidative stress and chronic inflammation (Björk et al, 2016; Min et al,
2015; Olejnik et al, 2016; T. Wu et al, 2016). Anthocyanins present an accessible solution for
attenuating oxidative stress in the RPE, as these compounds are readily available in red, blue,
and purple fruits and vegetables and can also cross the blood-retina barrier (Matsumoto et al,
2006). We found that the anthocyanins callistephin and oenin protect RPE cells from blue-light
mediated oxidative stress at low supplement concentrations. We also analyzed anthocyanin
oxidation products, proposing structures for these species that would be produced in a stressed
cellular environment. Our results support the efficacy of plant-derived antioxidants in protecting
the RPE from oxidative damage, and further characterizing the cellular interactions of these
compounds would prove beneficial for expanding our knowledge of their therapeutic potential in
the retina.
Aging is a complicated process, involving a multitude of factors that range from genetic
predisposition to environmental triggers. This works centers on the role of RPE melanin in
disease progression and explores simple therapeutics to address age-related damage to the RPE.
The results presented in this dissertation suggest that RPE melanin is capable of mediated
immune response and the production of immunogenic substrates, specifically reactive oxygen
and nitrogen species. This novel role for RPE melanin extends into age-related changes to the
pigment, namely oxidative degradation. Structural compromise to RPE melanin changes the
reactivity of the pigment, and our results suggest these changes may facilitate tissue damage via
pro-oxidant effects. The protective ability of RPE melanin can be supplemented with dietary
antioxidants to in part address these pro-oxidant effects. Readily available therapeutics, such as
L-DOPA, can also attenuate damage to the RPE by regulating secretion of neurotropic factors
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and growth factors. Using a liposomal delivery system, therapeutics can be safely and
effectively delivered to the retinal space in AMD patients.
Maintaining the health of RPE cells is paramount in preserving vision. Oxidative stress
and chronic inflammation are critical components of disease pathogenesis. The role of RPE
melanin in the age-related changes to the retina can provide insight into risk factors and
treatment options for preventing the development and progression of AMD. Antioxidant
supplements can support endogenous antioxidants in the RPE by preventing the generation of
reactive oxygen and nitrogen species. By having a more complete understanding of the
molecular mechanisms of aging in the retina, specific and effective therapeutics can be
developed to treat disease.
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APPENDIX

AUTHENTICATION OF ARPE-19 CELL LINE
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Your submitted cell line profile is similar to the cell line(s) below found in the DSMZ database (>0.8 EV) and, therefore, is considered related by ANSI/
ATCC ASN-0002-2011, Authentication of Human Cell Lines: Standardization of STR Profiling guidelines.
Your submitted cell line profile is human, but does not match any reference profile in the DSMZ database with an EV >0.8.
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Your submitted cell line profile is an exact match to the below cell line(s) found in the DSMZ.
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Your submitted cell line profile is similar to the below cell line(s) reference profile found in the ATCC database (>80% to 99% match) and is considered
related by ATCC’s percent match algorithm.
Your submitted cell line profile is human, but it does not match any reference profile in the ATCC database with a >80% match.
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Raw Data Table:

A Promega GenePrint 10 Kit was used to polymerase chain (PCR) amplify eight short tandem repeat (STR) loci plus a gender determining
marker, Amelogenin. The PCR product was electrophoresed on an ABI Prism® 3730xl Genetic Analyzer using an Internal Lane Standard 600
(Promega). Data was analyzed using GeneMapper® v 4.0 software (Applied Biosystems). Appropriate positive and negative controls were used.

Procedure:

Search results and matching values (% match and EV) are presented as represented in the ATCC, DSMZ and JCRB databases.
The ATCC, DSMZ, and JCRB databases only provide STR information for markers amelogenin, CSF1PO, D13S317, D15S539, D5S818, D7S820,
THO1, TPOX, and vWA. Marker D21S11, D13S1358, D8S1179, FGA, Penta D, and Penta E cannot be confirmed by these databases.
The GRCF follows the ATCC Standards Development Organization guidelines given in the ASN-0002, Authentication of Human Cell Lines:
Standardization of STR Profiling for determining if a cell line is considered related, probably unrelated, or unrelated.
Please see the Pdf file Additional Information sent with the results for more information about interpreting your STR profile.
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